Role of Apolipoprotein D and Its Homologs, in Normal and Pathological Aging, in Drosophila melanogaster by Muffat, Julien A.
Role of Apolipoprotein D and its homologs, in normal and 
pathological aging, in Drosophila melanogaster 
 
 
Thesis by 
Julien A. Muffat 
 
 
In Partial Fulfillment of the Requirements 
 For the Degree of  
Doctor of Philosophy 
 
 
California Institute of Technology 
Pasadena, California 
2009 
(Defended December 17th, 2008) 
 
i 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2009 
Julien A. Muffat 
All Rights Reserved 
ii 
 
Acknowledgement 
I would like to dedicate this manuscript to my family back in France. While I 
have enjoyed every minute of my time working on this project, I have missed you terribly 
over the years. I would not be here today if my parents, Annie and Pierre, had not always 
encouraged my curiosity, and supported me in all my endeavors, with their ups and 
downs. My grandparents, Mammina and Gigi, Mami and Papi, are certainly responsible 
for instilling in all of us this taste for excellence, and this conviction that a good 
education is a key to happiness. My brothers, Jerome and Romain, have provided the 
healthy emulation needed to achieve success, academic or otherwise. A special note to 
my dear uncle Paul, whose own career in science is a true inspiration, and who, more 
than anyone, has shaped my drive to understand the natural world and its wonders. And 
of course, thanks to everyone else, who have always made family gatherings so pleasant 
and exciting; I only wish I could see you more often. Finally, in my adoptive land, I 
would not have even functioned properly without my dear Meghan’s love and support. 
Thank you all so much, I love you dearly.  
In this adventure, I had the infinite pleasure of meeting one of my scientific 
heroes, Seymour Benzer. I had the luck of working by his side for 5 wonderful years, and 
discussing, daily, as a peer and a friend, everything from food to hard drive mechanics. 
He assembled around himself a wonderful team of scientists and technicians; I am 
indebted to all of them, and in particular to David Walker. Seymour was the most 
available of mentors, only making it more absurdly tragic when he left us a year ago. His 
legacy lives on, and I am very proud to have had this chance to know him and learn from 
him. I can only hope his brand of curiosity will stay with me till the end.  
iii 
 
Abstract 
The free radical theory of aging is probably the most enduring one to date. It stipulates 
that, in the process of normal cellular function, in particular due to oxygen-based 
respiration, reactive oxygen species are formed. These constantly put a strain on the cell, 
damaging lipids in the membranes, causing protein aggregation and loss-of-function, or 
mutations in the genome. Over time, this accumulated damage overcomes the repair 
potential of a given cell, and scaled up to an entire organism, results in the deterioration 
seen in normal aging. Under these assumptions, age-related pathologies are only an 
acceleration of the process in a given tissue, leading to the emergence of the pathology 
over the noise of normal aging. In the past decade, invertebrates such as Drosophila 
melanogaster and C. elegans have provided invaluable insight into these processes and 
the canonical pathways that regulate them. This success is owed in part to the power of 
the genetic tools available, to their relatively short lifespans, and to the wide arrays of 
phenotypes that can be studied. We set out to study a particular protein, Glaz, whose 
overexpression enables fruitflies to live 30% longer than normal. This protein was 
identified as a hit from a screen looking at an accelerated aging paradigm, placing 
fruitflies in 100% oxygen. While an interesting protein in its own right, it was through its 
homology with mammalian Apolipoprotein D (ApoD), that our interest was truly piqued. 
ApoD and its homologs turn out to be fascinating proteins, upregulated by various 
stresses and in age-related diseases such as cancers and Alzheimer’s. We showed, in our 
model organism of choice, that this upregulation is part of a beneficial stress response. 
Understanding and harnessing its functions can only help provide therapeutic approaches 
for a wide range of disorders. 
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Summary 
 
The process of aging is understood to be a general 
deterioration over time of the cells, tissues, and organs of an 
organism, ultimately reducing normal function and increasing the 
probability of mortality. Aging is a complex process that involves a 
multitude of both environmental and genetic factors that ultimately 
results in the determination of an organism’s lifespan. However, there 
is some hope in the fight against aging: slight alterations in many of 
these factors can result in significant increases in both mean and 
maximum lifespan. It has been known for some time that fruit flies 
can be selectively bred for extended lifespan. While the results from 
these experiments are certainly encouraging they fail in one key 
aspect, they deal with a complex set of mutations in multiple genes 
making it difficult to identify the part of the aging process that has 
been altered. A more rewarding avenue of exploration is the 
characterization of single gene mutants that appear to regulate 
lifespan. Already many single gene mutations have been identified 
within a variety of model organisms, which include but are not limited 
to yeast, C. elegans, Drosophila, and mice. Within our model 
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organism of choice, D. melanogaster, the discovery of these lifespan-
extending single-gene mutants has been a recent advance with the 
first such mutant, methuselah (mth) being identified in 1998 in the 
Benzer lab. 
 
The connection between aging and free radicals has been 
around for a long time, with the original “free radical theory” of aging 
being proposed by Denham Harman in the 1950s. At present, it is 
generally understood that as a by-product of normal metabolic 
activities certain reactive oxygen species (ROS) are produced and 
then damage a variety of cellular macromolecules including nucleic 
acids, proteins, and lipids. The accumulation of this damage over the 
lifetime of the organism is then thought to give rise to some of what 
we understand to be the aging phenotype. More evidence for this has 
been found from long-lived mutants such as mth and daf-2 (in 
nematodes). In particular, it has been shown that mth exhibits an 
increased resistance to dietary paraquat, which produces superoxide 
anions (O2-). Long-lived daf-2 mutants are similarly resistant to 
hydrogen peroxide and have additionally been shown to upregulate 
the catalase transcript and SOD-3, both of which are enzymes used 
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in converting ROS to water. Moreover, in the case of long-lived p66shc 
mice it has been shown that cultured fibroblast cells from the tail 
exhibit an increased survivorship when exposed to hydrogen 
peroxide. 
What makes Drosophila useful as a model system for studying 
aging is in large part what makes it useful as a model genetic 
organism: a short life cycle (~14 days) and a low cost of husbandry. 
The most important features of D. melanogaster in studying aging are 
the multitude of molecular and genetic tools available to study the 
particular genes of interest. The first of these are the large number of 
well-characterized P-element insertion collections that are widely 
available. These provide a vast number of different mutant lines that 
can be screened in a straightforward manner for desired 
characteristics. Many of the current fruit fly aging mutants have in fact 
been identified from these collections, including mth. Additionally, 
many of these collections have been generated with P-elements that 
contain UAS (upstream activating sequences) that can be coupled to 
lines that express the GAL4 protein in certain tissue specific manors. 
GAL4 binds to the UAS regions of the P-element and is able to drive 
the expression of genes downstream of the insertion site. This 
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provides a unique ability to look at the effects of under-expression 
and tissue specific overexpression in the same mutant lines.  
  
Toward a genetic dissection of the oxygen defense pathway, a 
genetic screen of approximately 1000 UAS-containing P-element 
insertion lines on chromosome 2 of D. melanogaster was undertaken. 
The flies were incubated for their entire lifespan in 100% O2. We 
identified lines that displayed a significantly altered sensitivity (shorter 
or longer lifespans) to oxidative stress. From this, 20 lines were 
identified as exhibiting hypersensitivity to hyperoxia. The focus of the 
project has been to characterize these mutants as a method of 
identifying genes involved in stress resistance, as we hypothesize 
that such genes are likely to be involved in aging. We started this 
project, focusing on one of these genes, Glial lazarillo, which 
exhibited the stronger overexpression phenotypes. Glial Lazarillo is a 
homolog of human Apolipoprotein D. In the following chapter 1, the 
reader will find a review of the current state of knowledge on ApoD. In 
chapter 2, we describe the original results of the screen, and the 
characterization of GLaz overexpressors. In chapter 3, we went on to 
study the regulation of GLaz expression in normal flies, as well as the 
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effect of Glaz expression in a more reductionist cell culture system. In 
this chapter, we also describe the study of flies overexpressing 
human ApoD, and the resulting increase in longevity and stress 
resistance. Finally, in chapter 4, we report the effects of gain and loss 
of function of the other Drosophila homolog of ApoD, Neural Lazarillo, 
and tie them to other canonical pathways known to control aging and 
stress resistance, the insulin signaling pathway, and the JNK 
pathway. 
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Chapter 1 
 
Apolipoprotein D: An Overview of its Role in Aging and Age-
Related Diseases 
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 “It’s got to be doing something important!”-Seymour Benzer, 
reflecting on the observation that ApoD mRNA levels increase 500-
fold following neuronal crush injury. Seymour Benzer‟s curiosity was 
legendary and seemingly limitless (Anderson and Brenner 2008; 
Dudai 2008; Greenspan 2008; Jan and Jan 2008; Tanouye 2008).  
Towards the end of his life, one of the (many) questions that kept him 
awake at night concerned the emerging role of Apolipoprotein D 
(ApoD) in aging and neurological disease.  In this review, we will 
discuss the clinical and biochemical data on ApoD, and the input from 
the recent genetic studies in model systems, including those from the 
Benzer lab. 
 
If the current literature is any indication, ApoD is getting more 
and more interest as a marker of disease. In fact, it was recently 
shown to be the most upregulated gene, commonly conserved 
between mice, monkeys and humans, as they age (Loerch, Lu et al. 
2008). While the picture painted by Loerch et al. also higlights the 
great differences in aging transcriptomes, it is striking to find that 
ApoD, which has not diverged that much from ancestral bacterial 
homologs, is elevated in old and sick animals, and that data 
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accumulates showing that this response is mostly beneficial. Our own 
work extends such data to Drosophila homologs of ApoD, and 
demonstrates, along with data obtained in transgenic mice, that 
increased human ApoD is beneficial to an aging or ailing organism. 
These provide tantalizing foundation for the further study of ApoD‟s 
regulation and action, with regards to therapeutic potential. 
 
Molecular Biology of ApoD 
 
Human ApoD was first formally identified in plasma high density 
lipopoproteins (HDL) in 1973 (McConathy and Alaupovic, 1973). The 
cDNA is 855 bp long (Drayna, Fielding et al. 1986), processed from a 
gene region with 5 exons spanning 20 kbp, typical of the superfamily 
(Sanchez, Ganfornina et al. 2003). In silico promoter analysis 
(Lambert, Provost et al. 1993) identified multiple steroid response 
elements (RE) upstream of ApoD. Further analysis in cell culture (Do 
Carmo, Seguin et al. 2002) showed the gene was also under the 
primary control of serum-responsive elements during cellular growth 
arrest, and has response elements for oestrogen, glucocorticoids, 
progesterone, and vitamins A and D.  
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In humans, the protein is widely expressed, hinting at 
fundamental cellular functions.  Other apolipoproteins are mainly 
produced by the liver, while ApoD‟s main sites of expression are the 
brain and the testes. It is expected to be transported through the 
bloodstream, while a different pool resides in the cerebrospinal fluid 
(CSF). In the central nervous system, it seems to be mainly 
expressed by glial cells (both astrocytes and oligodendrocytes) and 
their precursors (Hu, Ong et al. 2001), but can also be expressed by 
neurons in pathological situations. In the peripheral nervous system, 
it is primarily secreted by endoneurial fibroblasts (Boyles, Notterpek 
et al. 1990). 
The protein itself is predicted to be small (18 kD), soluble and 
secreted. It has no homology to other apolipoproteins (such as the 
well-known ApoE). Early studies showed diverse levels of 
glycosylation, sometimes specific to expression site (as in axillary 
secretions, (Zeng, Spielman et al. 1996)). Based on its primary 
sequence, it was expected to be a member of the lipocalin family of 
proteins. These are cup-shaped molecules, presenting 8 beta-pleated 
sheets arranged in a calyx structure, capable of binding a single 
hydrophobic ligand in the pocket they form.  Such a predictive 
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structure was originally proposed upon alignment with bilin binding 
protein (BBP), and recently confirmed by the 1.8 Å structure of a 
hydrophilized form of recombinant ApoD  (Nasreen, Vogt et al. 2006); 
(Eichinger, Nasreen et al. 2007). These studies highlighted the 
presence of hydrophobic residues outside of the binding pocket, 
which may allow the molecule to interact with membranes or HDL, 
and favor ligand exchange, while the base of the calyx could provide 
a docking site for an unidentified cellular receptor.  
Both the crystallization studies and earlier affinity assays 
(Morais Cabral, Atkins et al. 1995);(Vogt and Skerra 2001), point to 
arachidonic acid (AA) and progesterone (PG) as the best putative 
physiological ligands for ApoD. Cholesterol itself was originally 
thought to be a primary candidate, and the jury is still out on its 
affinity for ApoD under physiological conditions. Finally, cysteine 
residues may allow homodimerization or the covalent linking of ApoD 
with partner proteins such as apolipoprotein AII. 
From these biochemical characterizations and the lack of data 
on physiological ligands, a complicated picture for ApoD biology 
emerges. The protein is expressed in many different tissues, with 
different glycosylation profiles. It can bind with micromolar affinity 
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several ligands and interact with membranes and circulating lipid 
particles. Its expression appears to be under the control of a complex 
array of regulatory elements. ApoD is realistically a protein with 
multiple ligands and interacting partners, through which it can exert 
multiple different functions in different tissues. It is in this context, a 
veritable terra incognita of actual functions, that our lab became 
interested in the study of ApoD and its homologs. For years, the 
Benzer lab was interested in the genetics of aging, and more 
specifically pathological processes related to neurodegeneration. 
Many studies have, in fact, identified ApoD as a good marker of 
several pathological processes, especially in the nervous system. 
 
ApoD and Psychiatric Disorders 
 
ApoD is associated with psychiatric disorders such as 
schizophrenia and bipolar disorder. Loci neighboring the human 
chromosomal locus for ApoD have been linked with these disorders 
(Camp and Farnham 2001); (Thomas, Dean et al. 2003). Circulating 
ApoD is elevated in the serum of schizophrenic patients receiving no 
medication, and in the brains of treated patients (Thomas, Dean et al. 
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2001); (Mahadik, Khan et al. 2002). Similarly, a 2-fold increase in 
ApoD can be found in the prefrontal cortex of patients with either 
schizophrenia or bipolar disorder, but a concurrent 2-fold increase in 
the parietal cortex appears to be specific to patients with bipolar 
disorder (Thomas, Dean et al. 2003). It is possible that elevation of 
ApoD in these specific regions is related to the membrane pathology 
observed in these disorders. Indeed, lipid homeostasis has been 
implicated in the pathogenesis of schizoaffective diseases, with 
evidence for AA and phospholipase A2 (PLA2) dysfunctions (Yao JK, 
2000). It is therefore interesting to find that high ApoD levels correlate 
with membrane AA in erythrocytes of schizophrenic patients (Yao, 
Thomas et al. 2005). Moreover, in human cells in culture, transfected 
apoD results in higher membrane-bound AA content, and retention 
when AA secretion is stimulated by PLA2 activation. Also, exogenous 
ApoD can prevent AA uptake by the cells (Thomas, George et al. 
2003), exemplifying a scavenger role for ApoD against free AA.  
Interestingly, atypical antipsychotic drugs such as clozapine, 
which work best in treating these psychiatric disorders, further elevate 
the levels of ApoD. Conversely, typical antipsychotic drugs, such as 
haloperidol, downregulate expression of ApoD. Haloperidol is known 
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to eventually cause cell damage and tardive dyskinesia in patients. 
Free arachidonic acid is the starting point for the synthesis of 
prostaglandins, and an inflammation cascade that can lead to further 
neuronal damage. One may therefore suggest that ApoD elevation in 
these disorders, and a further boost by drugs, can act to prevent 
deleterious events, stabilizing membrane bound AA.  
 
ApoD in Neurological Disorders and Injury to the Nervous 
System 
 
ApoD has also been described in association with various 
neurological disorders, many of them age related. Oxidative stress 
can be considered an underlying common denominator in most of 
these pathologies. For example, an imbalance in reactive oxygen 
species (ROS) production and clearance in the dopaminergic 
neurons of the substantia nigra (SN) is often considered to be a 
cause of Parkinson‟s disease (PD). In fact, many genes linked with 
familial Parkinson‟s disease appear to be implicated in mitochondrial 
function, and dopamine metabolism itself can produce free radicals. 
Recently, it was reported that high levels of ApoD could be found in 
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the SN of patients with PD (Ordonez C, 2006). In this case, the 
neurons that are the target of the pathology do not express ApoD, but 
glial cells surrounding them display an increased immunoreactivity. 
ApoD is elevated in normal aging brains (Kalman, McConathy 
et al. 2000); (Thomas, Laws et al. 2003), but more strongly so in 
patients with Alzheimer‟s disease (2–fold elevation over age-matched 
controls). In these patients, expression can be seen 
immunohistochemically in oligodendrocytes and astrocytes, but also 
in neurons affected by neurofibrillary tangles, and in the vicinity of 
amyloid plaques. We and others have observed an increase in 
cortical and hippocampal ApoD immunoreactivity with advanced AD 
stages. It is worth noting that a particular allele of ApoD (intron 1) was 
enriched in AD patients, in a small African-American sample (Desai, 
Hendrie et al. 2003), while another allele (-352G SNP) was enriched 
in a Finnish population with early onset AD (Helisalmi, Hiltunen et al. 
2004). This association with AD may be linked to cholesterol 
homeostasis theories of AD etiology. By controlling membrane 
composition, and perhaps binding cholesterol itself, ApoD may play a 
part in initiation of the amyloid cascade. 
15 
 
Since ApoD is a lipid carrier, it is particularly interesting to 
observe its upregulation in disorders of the myelin sheath. Plasma 
and CSF ApoD levels are significantly elevated in multiple sclerosis 
and other inflammatory diseases of the central nervous system 
(Reindl, Knipping et al. 2001). As mentioned in our introduction, one 
of the most striking increases is observed in regenerating and 
remyelinating sciatic nerve, in the rat. After 3 weeks post-crush injury, 
ApoD increases 500-fold at the site of the lesion, and remains 
elevated while attempts at regeneration take course (Boyles, 
Notterpek et al. 1990).  
More recently, in a rat model of stroke, ApoD was found to 
increase up to a week after reperfusion, in the penumbra of the injury 
(Rickhag, Wieloch et al. 2006; Rickhag, Deierborg et al. 2008). It is 
important to note that ApoD protein levels, but not its mRNA, 
increased in the dying neurons. On the contrary, in the zone 
bordering the infarct, oligodendrocytes were shown to upregulate 
ApoD expression, thereby suggesting secretion and recruitment in 
the dying areas. 
In all those cases, and particularly in cases of acute insult, 
inflammation, oxidative stress and cell death are intertwined. As a 
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general rule, dying neurons and glia release an enormous amount of 
free cholesterol and arachidonic acid in the vicinity of the lesion. To 
prevent further damage, these lipids have to be cleared by 
surrounding glial cells. ApoD could provide a means to recycle these 
molecules, while making them available again to any subsequent 
regenerative process. Other apolipoproteins such as ApoE and 
ApoA-I have been studied in this context, and are thought to be 
necessary for regenerative lipid redistribution.  Such data is currently 
lacking for ApoD. ApoD is significantly elevated in ApoE knock-out 
mice (Terrisse, Seguin et al. 1999), and it is conceivable that this 
represents a compensatory mechanism for membrane remodeling in 
these mutant mice. 
 
ApoD and Cancer 
 
A quick look at the literature on ApoD will turn up many references to 
cancer (Hunter, Young et al. 2002; Hunter, Weiss et al. 2005; Hunter, 
Varma et al. 2005; Doane, Danso et al. 2006; Soiland, Skaland et al. 
2008), another age-related pathology.  It is worth remembering that 
ApoD was identified early on as the main protein of breast cyst fluid, 
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with a 1000-fold higher concentration than in plasma, along with very 
high concentrations of progesterone. Such cysts may be related to 
tumor formation, and to the presence of lower-grade tumors.  
Primarily, studies have observed the upregulation or 
downregulation of ApoD in tumor or stromal cells. They often 
consider ApoD as a biomarker, with potential prognostic value. As a 
general rule, high levels of ApoD in the tumor cells have been linked 
to low-grade tumors, and low proliferation. In cell culture, ApoD 
overexpression promotes quiescence. However, the picture is 
complicated since growth arrest triggered by stress (e.g., serum 
withdrawal), can itself upregulate ApoD (Do Carmo, Levros et al. 
2007). High expression of ApoD in the stroma surrounding a tumor 
may, in turn, be the mark of an invasive tumor, with poor prognosis. 
Speculatively, such an upregulation of ApoD in the stroma of an 
otherwise ApoD negative tumor is a paracrine attempt at limiting 
tumor proliferation. An ApoD positive tumor has its own autocrine 
supply of ApoD, capable of limiting its growth.  High levels of ApoD 
may not simply promote quiescence, but cell senescence. A 
senescent stroma is more likely to allow invasion and potential 
migration by tumor cells out of the primary site. Since it has been 
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shown in culture that ApoD expression can promote motility (Leung, 
Lawrie et al. 2004), it is also possible that, in some cases, high 
stromal ApoD would result in a particularly aggressive tumor, with 
greater metastatic potential. These observations may be tied 
mechanistically with the affinity of ApoD for AA and PG, and to the 
regulation of ApoD expression by steroid hormones.  
 
For example MAPK (ERK1/2) cannot translocate to the nucleus 
in the presence of ApoD (Sarjeant, Lawrie et al. 2003). The targets of 
MAPK would otherwise favor proliferation, in response to estrogen 
receptor (ER) activation, through its fast-acting pathway. Estrogens, 
acting through their slow-acting genomic pathways, can also 
downregulate ApoD expression, thereby promoting cell proliferation 
effects. In this context, a proper balance of ApoD, either expressed or 
taken up from the milieu, may have strong repercussion on tumor 
development.  
In addition the binding of ApoD to AA would prevent synthesis 
of prostaglandins and leukotrienes through the cyclooxygenase 
pathway (COX-2). These proinflammatory molecules are known 
activators of cell proliferation, inhibitors of apoptosis (Taketo and 
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Sonoshita 2002), and can even promote angiogenesis. ApoD 
elevation could act as a scavenger of AA, thereby decreasing tumor 
aggressiveness. 
 As mentioned earlier, PG is the second best candidate ligand 
for ApoD. It is therefore very possible that cytoplasmic ApoD would 
act as a sink for progesterone, either on its way to catabolism, or to 
control the kinetics of its transcriptional action. The picture is 
particularly complex, since, as with all steroid hormones, there are 
two competing pathways. Moreover the PG receptor (PR) comes in 
two flavors with opposite transcriptional effects, and opposite effects 
on cell proliferation. The net effect of ApoD presence on a functional 
PR response will depend on the isoform expressed in the particular 
cell of interest. 
 Very recently, an interesting cell culture study showed 
conclusively that ApoD is under the control of p53 family members 
(Sasaki, Negishi et al. 2009). P53 is probably the most well-studied 
tumor suppressor, and is found to be mutated or inactive in up to 70% 
of all cancers. In many ways, p53 may constitute a nexus between 
cancer and aging (Serrano and Blasco 2007; Campisi 2008). An 
overactive p53 may result in accelerated aging, through depletion of 
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renewal potential for a given tissue. A mildly overactive p53 pathway 
could have beneficial effects, promoting tissue quiescence and repair. 
An inactive p53 pathway would, in turn, promote tumor formation. The 
study of its close homologs p63 and p73 has provided some 
intriguing observations. Most notably, it appears that there may be 
some level of functional redundancy, as p73 has recently been 
characterized as tumor suppressor as well (Rosenbluth and Pietenpol 
2008). Some genes may respond to all p53 family members, while 
others may be specific to either p53, p63 or p73. In any case, Sasaki 
et al. demonstrate that the ApoD promoter can bind p63 and p73, and 
that p73 represents the functional activator. They observe that 
several phenotypes, relevant to cancer formation and cell 
senescence, are under the control of p73 through transactivation of 
ApoD. Indeed, in their system, proliferation and differentiation 
induced by p73 in osteosarcoma and astrocytoma cell lines, 
necessitates ApoD. Even DNA damage induced by cisplatin, which 
upregulates ApoD, appears to do so through p73 activation. Their 
result on the medulloblastoma cell line (SH-SY5Y), and how ApoD 
can drive neuronal differentiation, is particularly interesting, as it may 
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provide some information on the role of ApoD in brain maintenance 
and repair. 
 
Modeling the role of ApoD in Longevity and Stress Resistance 
  
 Our own interest in ApoD began when we performed a genetic 
screen to identify genes that protect the fruit fly Drosophila against 
oxidative stress and aging.  As is often the case, there were a 
relatively large number (~20) of „hits‟ from the screen (Walker, Hajek 
et al. 2006; Walker, Muffat et al. 2006).  One of these „hits‟, Glial 
Lazarillo (GLaz), was a fly homolog of human ApoD.  We remember 
vividly showing our mentor, Seymour Benzer, the very active flies that 
were overexpressing the ApoD homolog next to the very sickly 
control flies.  From that day on, we would discuss ApoD on an almost 
daily basis until the end of Seymour‟s life.  
 To validate the protective effects of Glaz, we generated 
independent transgenic lines carrying the GLaz cDNA under control 
of the UAS/GAL4 system (Brand and Perrimon 1993).  Upon doing 
so, we discovered that overexpression of Glaz protected against a 
range of extrinsic stressors and extended the lifespan of normal flies 
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by ~30% (Walker, Muffat et al. 2006).  An independent loss-of-
function study revealed that GLaz mutants are sensitive to both 
oxidative and starvation stress (Sanchez, Lopez-Arias et al. 2006). 
Interestingly, a GLaz-GFP reporter line was expressed in glial cells in 
the adult fly brain.  This expression pattern is consistent with the 
developmental expression pattern of GLaz in Drosophila (Sanchez, 
Ganfornina et al. 2000), and with the mainly glial expression pattern 
of vertebrate ApoD (Sanchez, Ganfornina et al. 2002; Navarro, Del 
Valle et al. 2004; Ganfornina, Sanchez et al. 2005).  In addition, GLaz 
gene activity was found to protect against neuronal apoptosis as a 
function of both age and extrinsic oxidative stress (Sanchez, Lopez-
Arias et al. 2006).  At a physiological level, GLaz mutant flies display 
decreased fat content (Sanchez, Lopez-Arias et al. 2006), 
highlighting a putative role for GLaz in lipid metabolism.   
 Recently, two additional studies have reported characterizing 
the function of ApoD orthologs in mammals (Ganfornina, Do Carmo 
et al. 2008) and also in plants (Charron, Ouellet et al. 2008).  An 
ApoD knockout mouse (ApoD-KO) was generated by replacing the 
wild-type ApoD gene with a copy interrupted by the insertion of the 
neomycin resistance gene, which rendered a transcription null 
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mutant.  Interestingly, ApoD-KO mice display reduced locomoter and 
exploratory behavior as well as deficits in learning (Ganfornina, Do 
Carmo et al. 2008).  Remarkably, murine ApoD appears to protect 
against oxidative stress also.  ApoD null mice display reduced 
tolerance to the ROS generator paraquat.  This result was observed 
in two different genetic backgrounds, strongly indicating that loss of 
ApoD gene function is responsible for the phenotype.   Bioinformatic 
studies have revealed that plants also possess lipocalins, which were 
classified as temperature-induced lipocalins (TILs), including the 
ApoD ortholog AtTIL identified in Arabidopsis thaliana (Charron, 
Ouellet et al. 2005).  AtTIL knockout plants are acutely sensitive to 
oxidative stress, cold and light (Charron, Ouellet et al. 2008). 
Whereas, overexpression of the normal gene confers resistance to 
extrinsic stress. 
 
 The upregulation of human ApoD (hApoD) in various diseases 
involving chronic stress predicts that experimentally induced stress 
may regulate the expression of ApoD orthologs in model systems.  To 
gain insight into this question, we examined the regulation of GLaz 
(fly ortholog of ApoD) as a function of extrinsic stress.  Quantitative 
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real-time PCR (qRT-PCR) revealed that GLaz mRNA levels were 
dramatically increased in response to dietary paraquat, hyperoxia or 
heat stress (Muffat, Walker et al. 2008).   A careful study in mice has 
revealed the temporal and spatial expression of ApoD in response to 
oxidative stress (Ganfornina, Do Carmo et al. 2008).  An acute up-
regulation of ApoD in mouse brain was observed 3 hours after 
exposure to paraquat, and the expression returns to baseline by 24 
hours. No up-regulation was observed in the lung or liver. In plants, 
AtTIL is induced by both thermal and water stress (Frenette Charron, 
Breton et al. 2002). Understanding the relationship between different 
stressors and ApoD induction may shed light on the mechanisms 
underlying neurological disease. Toward this goal, a recent study 
examined the response of ApoD to a range of stressors in cell culture 
(Do Carmo, Levros et al. 2007). Interestingly, stresses that cause an 
extended growth arrest, such as UV light or hydrogen peroxide, 
increase ApoD expression. At the same time, lipopolysaccharide 
(LPS) a proinflammatory agonist was able to induce ApoD 
expression, perhaps hinting at a feedback inhibitory loop. This study 
also addressed the subcellular localization of ApoD under normal and 
stressful conditions. Interestingly, under normal conditions ApoD is 
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mainly perinuclear but it accumulates in the cytoplasm and nucleus 
under stressful conditions. In fact, exogenous ApoD from the medium 
can be taken up by cells and translocated in this way, making the 
search for the receptor(s) involved in this trafficking a high priority in 
ApoD research. These studies in plants, insects and mammals 
strongly support a conserved function for these lipocalins, responding 
to and protecting against extrinsic and intrinsic stress. 
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Manipulating Human ApoD (hApoD) Gene Function In Vivo 
 
As outlined above, ApoD homologs in model systems appear to show 
conservation of both regulation and function. But what about the 
human gene itself? To examine the role of hApoD on longevity and 
stress resistance directly, we generated two independent transgenic 
fly lines carrying the hApoD cDNA under control of the UAS/GAL4 
system (Brand and Perrimon 1993). Using this system, we have 
shown that overexpression of hApoD in flies protects against 
oxidative stress and extends lifespan under normal conditions 
(Muffat, Walker et al. 2008). To examine the role of hApoD in mice, a 
transgenic animal (HApoD-Tg) overexpressing hApoD under the 
control of a neuronal promoter was generated (Ganfornina, Do 
Carmo et al. 2008).  Indeed, HApoD-Tg mice display improved 
survival following exposure to two different concentrations of 
paraquat. More recently, Do Carmo et al. showed conclusively that 
ApoD overexpression is sufficient to temper inflammation observed in 
coronavirus-induced encephalitis (Do Carmo, Jacomy et al. 2008). 
The study of mutant mice in similar conditions would greatly inform 
our current understanding of some of ApoD‟s physiological functions. 
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Conclusion 
 
Such results highlight the exciting studies that can stem from 
animal models, whether using ApoD homologs or human ApoD 
transgenics. It is easy to see how further studies of these fly and 
mouse strains can inform the processes in which ApoD is now 
thought to play an important role, which we highlighted in this review. 
We note that whether we consider cancers, neuronal disorders, or 
wound healing, there is an underlying age-dependency. In part, the 
involvement of ApoD in these disorders could be related to a direct 
scavenging activity against free-radical damage. Studies in both mice 
and fruitflies have shown ApoD‟s ability to decrease lipid peroxides in 
membranes. In mice, it is quite possible that this effect is exerted on 
inflammatory pathways, or more directly on clearance of peroxidized 
arachidonic acid. In any case, the community working on this protein 
and its homologs has only started to scratch the surface of ApoD‟s 
mechanisms of action. Over the years, ApoD has been studied from 
widely different angles, which are today primed to coalesce, and 
provide a significant new understanding of its various roles. The 
recent elucidation of its crystal structure can only benefit biochemical 
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studies of ligands and interacting partners, and provides educated 
targets for mutational analysis. We believe ApoD constitutes an 
important therapeutic target for several devastating diseases. 
Harnessing its beneficial powers will rely on accurate understanding 
of its regulation and functions. If direct ligand interactions are involved 
in these therapeutic approaches, it is important to note that ApoD will 
benefit from work to generate anticalins, engineered lipocalins, with 
customized affinities for lipidic ligands of choice (Vogt and Skerra 
2004). 
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Chapter 2 
 
 
Overexpression of a Drosophila Homolog of Apolipoprotein D 
Leads to Increased Stress Resistance 
 and Extended Lifespan 
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Summary 
 
An increase in Apolipoprotein D (ApoD) expression has been 
reported in a number of neurological disorders, including Alzheimer's 
disease, schizophrenia and stroke, as well as in the aging brain 
(Rassart, Bedirian et al. 2000). However, whether ApoD is toxic or 
part of a defense strategy is unknown.  
In a screen to identify genes that protect Drosophila against 
acute oxidative stress, we isolated a fly homolog of ApoD, Glial 
Lazarillo (GLaz). We generated independent transgenic lines, and 
found that overexpression of GLaz resulted in an increase in 
resistance to hyperoxia (100% O2) as well as a 29% extension of 
lifespan under normoxia. These flies also displayed marked 
improvements in climbing ability and locomotion activity, after sub-
lethal exposure to hyperoxia. Overexpression of Glaz also increased 
resistance to starvation, without altering lipid or protein content. To 
determine whether GLaz might be important in protection against 
reperfusion injury, we subjected the flies to hypoxia, followed by 
recovery under normoxia.  Overexpression of GLaz was protective 
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against behavioral deficits caused in normal flies by this ischemia/ 
reperfusion paradigm.  
This and the accompanying paper by Sanchez et al. are the 
first to manipulate the levels of an ApoD homolog in a model 
organism. Our data suggest that human ApoD may play a protective 
role, and thus may constitute a therapeutic target to counteract 
certain neurological diseases. 
 
Results:  
 
Overexpression of GLaz confers resistance to hyperoxia, as well 
as lifespan extension in normoxia. 
 
Oxidative stress has been widely implicated as an underlying 
mechanism in the pathology of neurodegenerative disorders, 
including Alzheimer's disease (AD) and schizophrenia (Yao, Reddy et 
al. 2001; Andersen 2004), as well as in the injury resulting from 
stroke (Chan 2005).  In addition, an overwhelming body of evidence 
supports the idea that reactive oxygen species (ROS) are a major 
cause of aging (Harman 1957; Balaban, Nemoto et al. 2005).  As the 
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formation of ROS is a function of ambient oxygen concentration 
(Turrens 2003), exposure to hyperoxia (100% O2) offers an attractive 
model for physiological studies of oxidative stress.   
We therefore performed a screen to identify genes that confer 
increased resistance to hyperoxia. This and all the subsequent 
experiments in this report were performed with male flies only. We 
drove high-level expression of various genes by crossing Enhancer 
Promoter (EP) element lines (Rorth, Szabo et al. 1998) having known 
insertion sites, with a driver line providing a ubiquitous GAL4 source, 
namely daughterless (da-GAL4).  One of the lines, EP(2)2383, 
carrying an insertion on the second chromosome, displayed a striking 
GAL4-dependent phenotype and was chosen for further study. Flies 
carrying both EP(2)2383 and da-GAL4 are much more resistant to 
hyperoxia (Figure 1A). The insertion in EP(2)2383 is 1.5 kb upstream 
of Glial Lazarillo (GLaz). RT-PCR confirmed that the EP(2)2383 
insertion causes a GAL4-dependent upregulation of the GLaz 
transcript (Figure S1). A microarray showed a 7-fold upregulation of 
the GLaz transcript, while nearby genes (NrkI, TppII, SptI and 
CG17724) in the genomic region were not affected (data not shown).  
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Glial Lazarillo (Glaz) is a Drosophila homolog of human 
Apolipoprotein D (ApoD), with 40% identity and 80% similarity to the 
human protein. Both are predicted to be very similar to the ancestral 
proteins that gave rise to the lipocalin family (Ganfornina, Gutierrez et 
al. 2000; Gutierrez, Ganfornina et al. 2000; Sanchez, Ganfornina et 
al. 2000). ApoD is a member of the lipocalin family, cup-shaped 
soluble molecules able to carry hydrophobic ligands in a 1:1 molar 
ratio. The physiological ligand for ApoD is undetermined, although, 
based on binding studies, arachidonic acid and steroids are the best 
candidates (Vogt and Skerra 2001). In Alzheimer’s disease, both 
mRNA and protein levels of ApoD are dramatically increased (350% 
in the cerebro-spinal fluid), and the protein is recruited to the amyloid 
plaques (Terrisse, Poirier et al. 1998; Kalman, McConathy et al. 
2000; Navarro, Del Valle et al. 2003). Following crush injury of the rat 
sciatic nerve, regeneration is accompanied by a 500-fold upregulation 
of ApoD at the site of the lesion, for several weeks after the injury 
(Boyles, Notterpek et al. 1990; Spreyer, Schaal et al. 1990). Neuronal 
degeneration induced by kainic acid triggers an upregulation of ApoD 
in the affected area (Ong, He et al. 1997). An increase in ApoD 
expression has been detected in a murine model of Niemann-Pick 
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disease type C (NPC), an inherited lysosomal cholesterol disorder 
(Suresh, Yan et al. 1998). Elevated ApoD expression has been 
reported in schizophrenia and bipolar disorder (Thomas, Dean et al. 
2001; Sutcliffe and Thomas 2002; Thomas, Copolov et al. 2003).  
ApoD levels have also been reported to increase with aging, in both 
humans and mice (Kalman, McConathy et al. 2000; Lee, Weindruch 
et al. 2000).   
In general, there is a strong correlation between resistance to 
oxidative stress and increased longevity (Larsen 1993; Sun and 
Tower 1999; Melov, Ravenscroft et al. 2000; Sun, Folk et al. 2002; 
Schriner, Linford et al. 2005). Therefore, we measured the lifespan 
under normoxia of flies carrying EP(2)2383 and da-GAL4.  
Overexpression of GLaz led to an increase in mean lifespan at 29°C 
of 18% (p<0.001, Figure 1B).   
 
Tissue-specific overexpression of GLaz. 
 
To study the overexpression further, and confirm that 
overexpressing GLaz was sufficient to cause the lifespan extension, 
we generated independent transgenic lines carrying the Glaz cDNA 
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under GAL4 regulation. The complete Glaz cDNA was cloned in the 
pUAST vector, thereby placing the insert under the control of UAS 
sequences within the boundaries of a P-element. Two independent 
transformants were generated (UAS-GLaz1, and UAS-GLaz2), both 
on the second chromosome. RT-PCR confirmed that both lines 
displayed GAL4-dependent upregulation of the Glaz transcript (Figure 
S2). Based on its relatively higher level of inducibilty, UAS-GLaz2 
was selected for further studies. 
To address whether specific tissues are responsible for the 
lifespan extension, UAS-GLaz2 and EP(2)2383 were crossed with 
GAL4 drivers having preferential patterns of expression in various 
tissues. Since GAL4 generally yields stronger effects at 29°C 
(Seroude, Brummel et al. 2002), we chose to perform these 
experiments at that temperature.  The control used was w1118, the 
host strain in which both UAS-Glaz contructs were generated.  The 
results are outlined in Table 1. Best results were obtained with 
relatively weak nervous system expression, combined with some 
expression in thoracic or abdominal muscles (PO163-GAL4, 
GAL4109(2)80). Drivers with expression primarily in the fat or in the 
muscles (DJ634, 24B) caused extension of lifespan, as compared to 
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the control crosses to w1118. GMR-GAL4, also induced a robust 
extension of lifespan. Although it is commonly described as an eye-
specific driver, we note that it also drives strong expression of a 
reporter in the salivary gland. When either the EP line or the cDNA 
transgene was driven by the strong nervous system drivers (D42-
GAL4, Elav-GAL4), there was no beneficial effect. No lifespan 
extension was observed with Actin-GAL4 or Hsp70-GAL4 when 
driving the cDNA transgene, although Actin-GAL4 did give a notable 
extension of lifespan when driving the EP line.  These results do not 
clearly identify a specific tissue as responsible for the phenotypic 
effects.  
One of the drivers, GAL4109(2)80, resulted in a particularly strong 
extension of lifespan with both the EP and the cDNA line. GAL4109(2)80 
is expressed especially in cells in the thoracic ganglion and the brain, 
and in the vertical flight muscles of the thorax (Figure 2A). While this 
pattern is maintained throughout adulthood (L. Seroude, personal 
communication), during development it is expressed in only a small 
subset of sensory neurons (Tracey, Wilson et al. 2003).  Flies 
carrying GAL4109(2)80 and EP(2)2383 displayed a 29% increase in 
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mean lifespan compared with the driver crossed to w1118 (Figure 2B) 
while driving UAS-GLaz2 results in a 23% increase (Figure 2C).  
Flies carrying both GAL4109(2)80 and UAS-GLaz2 displayed a 
12% increase in survival under hyperoxia (Figure 2D) compared to 
the driver control. To test whether the overexpressor flies also had 
improved vigor associated with their hyperoxia resistance, we 
performed behavioral assays.  After 4 days in hyperoxia both vertical 
and horizontal locomotor performances were much better in flies 
overexpressing GLaz, as compared to controls (Figure 3A and 3B).  
The same genotypes, when maintained under normoxia, showed no 
differences. 
 
Flies overexpressing Glaz are more resistant to starvation. 
 
Resistance to multiple extrinsic stressors is a hallmark of 
several long-lived mutants (Larsen 1993; Lithgow, White et al. 1995; 
Murakami and Johnson 1996; Lin, Seroude et al. 1998; Wang, 
Kazemi-Esfarjani et al. 2004). We tested flies overexpressing GLaz 
for resistance to wet or dry starvation.  Overexpression of Glaz led to 
a 60% increase in lifespan under wet starvation (Figure 4A) and a 
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30% increase under dry starvation (Figure 4B). Given the predicted 
nature of the protein as a secreted lipid carrier, we checked whether 
the flies overexpressing GLaz were larger, or displayed higher lipid or 
protein content. There was no significant difference in dry weight 
(Figure S3A), protein content (Figure S3B), or fat content (Figure 
S3C) between flies overexpressing GLaz, compared to the driver 
crossed to w1118. 
 
GLaz overexpression protects against behavioral deficits 
caused by hypoxia 
 
ApoD is upregulated in a mouse model of stroke (Trieu and 
Uckun 2000). Therefore, we tested the ability of flies that overexpress 
Glaz to withstand periods of oxygen deprivation, followed by recovery 
under normoxia. The flies were subjected to hypoxia in 100% N2 for 
30 minutes, then transferred back to a normoxic environment. After 
awakening, flies over-expressing Glaz were much more active than 
control flies. In our assay of vertical locomotion performance, one 
hour after their recovery, 75% of the GLaz overexpressors climbed to 
the top one third of the vial, while only 10-15% of control flies 
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managed to do the same (Figure 4C). This difference was still evident 
2 days later.  Before hypoxia exposure, no differences in climbing 
ability was observed. 
 
Discussion 
 
We report that overexpression of GLaz, using independent EP 
insertions or transgenic lines, can result in increased resistance to 
stress, and extension of lifespan. These results are consistent with 
ApoD being part of a damage-control system.  The mechanisms 
involved in these effects remain to be determined: GLAZ, and 
perhaps APOD, may transport lipophilic molecules to and from cells, 
thus helping to repair damaged membranes, or clear cholesterol and 
fatty acids released by dying cells. In mammals, the binding affinity 
for arachidonic acid may point to a role in the control of inflammation. 
They may also quench deleterious molecules such as lipid peroxides, 
or scavenge other free radicals. In the accompanying paper, Sanchez 
et al. observe a depletion of lipid stores in GLaz deficient mutants. 
GLAZ may work as part of a shuttle system, used to maintain stores 
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at a normal level, while providing support to other tissues in situations 
of stress.  
We screened multiple drivers, with multiple responder lines, 
and could not point to a single tissue as a necessary or sufficient site 
of upregulation to produce increased longevity. The amount of 
overexpression of such a secreted protein may matter more than its 
site of production. Furthermore, it must be borne in mind that the 
expression patterns of many drivers change during development and 
with age, and that GLaz is likely to be secreted. Interestingly, 
overexpression with strong neuronal drivers did not extend adult 
lifespan. In the accompanying paper, Sanchez et al. report that 
normal adult expression of GLaz is primarily in glial cells, and to 
some extent in the cardia and hemocytes. In embryos, the transcript 
is present in the nervous system (Sanchez, Ganfornina et al. 2000), 
and the developing gut. In the embryonic nervous system, Glaz is 
expressed in the longitudinal glia. These cells are known to be crucial 
for axon guidance and neuronal trophic support, and can be 
considered homologous to oligodendrocytes of vertebrates. 
Originally, the grasshopper homolog, Lazarillo, was found to be 
important for axon guidance (Sanchez, Ganfornina et al. 2000). One 
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of our most effective drivers, GAL4109(2)80, is expressed in adult 
vertical flight muscles, and, to a lesser extent, in the adult nervous 
system, but has a very restricted expression pattern during 
development. It is therefore possible that strong early overexpression 
in neurons has adverse effects that mask the benefits of GLAZ in the 
adult, where it may circulate in the hemolymph to reach its target 
tissues. 
Flies overexpressing Glaz fared much better in behavioral tests 
after hyperoxia exposure. We have recently shown that the flight 
muscle is one of the earliest tissues to suffer damage under 
hyperoxia, and that old flies also display some of the alterations seen 
under hyperoxic stress (Walker and Benzer 2004).  It is conceivable 
that overexpression of GLaz in the flight muscles (using GAL4109(2)80) 
is beneficial either by improving nutrient exchange, or by delaying 
cellular damage. In the mouse, ApoD is upregulated in response to 
cerebral stroke (Trieu and Uckun 2000). Some of the common 
therapies for victims of such damage aim at lowering the overall 
metabolism of the affected area, to decrease the oxidative burden on 
cells. We show that GLaz overexpression can protect against 
behavioral decline induced by exposure to hypoxia. GLaz 
52 
 
overexpression might make the flies more resistant to the cellular 
insult of the stresses studied here, and hastening the recovery.  
In recent years, Drosophila has become a powerful model for 
studying neurodegenerative disorders (Muqit and Feany 2002; Bilen 
and Bonini 2005).  Understanding how lipocalins regulate lifespan, or 
rescue neurological disorders in Drosophila may help to understand 
the role of ApoD in the human brain, and suggest ways of 
manipulating its expression and function, providing clues to potential 
therapeutic routes.  
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Figures and Legends: 
 
 
Figure 1 : Increase in hyperoxia resistance and extension of 
lifespan by overexpression of GLaz.  
 
A: Survival under hyperoxia (100% O2). da-GAL4 (ubiquitous GAL4 
driver) is used to activate the UAS sequences in EP(2)2383. Each 
graph represents a trial with at least 100 flies, typical of several 
repeated experiments. The EP overexpressor (w1118; EP(2)2383/+; 
da-GAL4/+, red curve) lives 20% longer (p<0.001) than the driver 
control (w1118; da-GAL4/+,  black curve). The dotted line represents 
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the EP alone (w1118; EP2383/+). B : At 29ºC, under normoxia, the EP 
overexpressor lives 18% longer than driver control. 
 
 
Table 1: Lifespan analysis of tissue-specific GAL4 driver lines.  
 
The different drivers are grouped by expression patterns. The first 
column shows the mean lifespan +/-SEM of each driver alone 
(crossed to w1118) as controls. The second column shows the mean 
lifespan +/-SEM of the various drivers crossed to EP(2)2383, and the 
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percentage difference with the driver control (n.s. = not significant). 
The third column displays the same information for each driver 
crossed to the transgenic cDNA insertion line UAS-GLaz2. Drivers 
that did not have a strong expression during development all gave 
good extensions of lifespan. The same drivers that extended lifespan 
of the EP line also increased lifespan of the cDNA transgenic line, 
with the exception of Actin-GAL4. 
 
 
Figure 2: Protection against hyperoxia and extension of lifespan 
by overexpression of GLaz using GAL4109(2)80 as the driver  
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A: X-GAL staining of a horizontal cryosection showing the adult 
expression pattern of the driver, using nuclear-LacZ under UAS 
control as a reporter. In the thorax, GAL4109(2)80 is expressed in the 
two vertical flight muscles (green dotted line), and in cells of the 
ventral ganglion (red dotted line). In the head, the driver is expressed 
predominantly in the retina and optic lobes (red arrows), and central 
brain areas (green arrow). B: EP line lifespan extension under 
normoxia, at 29ºC. GLaz EP overexpressors (w1118; 
GAL4109(2)80/EP(2)2383, red curve) live 23% longer (p<0.001) than 
driver control (w1118; GAL4109(2)80/+, black curve). The dotted line 
represents the EP alone (w1118; EP(2)2383/+). C: GLaz cDNA 
transgenic lifespan extension under normoxia, at 29ºC. GLaz cDNA 
overexpressors (w1118; GAL4109(2)80/UAS-GLaz2, red curve) live 23% 
longer (p<0.001) than driver control (w1118; GAL4109(2)80/+, black 
curve). The dotted line represents the transgene alone (w1118; UAS-
GLaz2/+). D: GAL4-dependent lifespan extension under hyperoxia in 
the transgenic flies. GLaz cDNA overexpressors live 12% longer 
(p<0.001) than the driver control. Each graph represents a trial with at 
least 100 flies, typical of several repeated experiments. 
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Figure 3: Overexpression of Glaz protects against hyperoxia-
induced behavioral decline. 
 
 A: Assay of vertical locomotion performance before (white bars) and 
after 4 days under hyperoxia (black bars). After hyperoxia, flies 
overexpressing GLaz (w1118; GAL4109(2)80/UAS-GLaz2) climbed 
significantly better than either control (w1118; GAL4109(2)80/+ or w1118; 
UAS-GLaz2/+, Student’s t test, p<0.001). B : Assay of horizontal 
locomotion performance before (white bars) and after 4 days under 
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hyperoxia (black bars). Flies overexpressing GLaz (w1118; 
GAL4109(2)80/UAS-GLaz2) performed significantly better than controls 
(w1118; GAL4109(2)80/+ or w1118; UAS-GLaz2/+, Student’s t test, 
p<0.001).  
 
 
Figure 4: Overexpression of Glaz increases resistance to 
multiple extrinsic stresses 
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A : Wet starvation. Flies over-expressing GLaz (w1118; 
GAL4109(2)80/UAS-GLaz2, red curve) lived 60% longer than driver 
controls (w1118; GAL4109(2)80/+, p<0.001). B : Dry starvation 
(desiccation). Flies over-expressing GLaz (w1118; GAL4109(2)80/UAS-
GLaz2) lived 30% longer than driver controls (w1118; GAL4109(2)80/+, 
p<0.001). Dotted line represent the transgene alone (w1118; UAS-
GLaz2/+). Each graph represents a trial with at least 100 flies, typical 
of several repeated experiments. C: Hypoxia. Assay of vertical 
locomotion performance after 30 minutes under hypoxia, followed by 
one hour recovery under normoxia. White bars represent 
performance before hypoxia exposure, with no significant difference 
between genotypes. Black bars represent performance after hypoxia 
exposure and recovery:  Flies over-expressing GLaz (w1118; 
GAL4109(2)80/UAS-GLaz2) climbed significantly better (Student’s t test, 
p<0.001) than either controls (w1118; GAL4109(2)80/+ or w1118; UAS-
GLaz2/+) 
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Supplementary figures: 
 
Figure S1 : RT-PCR showing a GAL4-dependent increase in 
GLaz transcript using the EP line.  
 
A : Marked increase in the amount of GLaz mRNA in w1118; 
EP(2)2383/+; da-GAL4/+ compared to the w1118; da-GAL4/+ and 
w1118; EP(2)2383/+ controls , consistent with GAL4 activation of UAS 
in EP(2)2383, enhancing Glaz trancription. Amounts of total RNA 
reverse transcribed were normalized. An RNA control was included to 
ensure equal loading after PCR (200 bp loading control) according to 
the Retroscript kit’s instructions. 
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Figure S2: RT-PCR showing a GAL4-dependent increase in GLaz 
transcript using the cDNA transgenic lines. 
 
Transgenic cDNA insertion lines UAS-GLaz1 and UAS-GLaz2. Both 
w1118; UAS-GLaz1/+; da-GAL4/+ and w1118; UAS-GLaz2/+; da-GAL4/+ 
display increases in the amount of GLaz transcript compared to 
controls.  A 200 bp rp49 RNA was also reverse transcribed and 
amplified to ensure that the reactions were properly normalized. 
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Figure S3 : Overexpression of Glaz does not alter weight, protein 
or lipid content.  
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A : comparison between flies over-expressing Glaz (w1118; 
GAL4109(2)80/UAS-GLaz2) and controls (w1118; GAL4109(2)80/+ or w1118; 
UAS-GLaz2/+) in terms of A: dry weight (in mg/fly), B: protein content 
(in mg/fly) and C: lipid content (percentage of dry weight). 
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MATERIALS AND METHODS 
 
Drosophila strains: Da-Gal4, 24B-GAL4, GMR-GAL4, PO163-
GAL4, Actin-GAL4, D42-GAL4, Elav-GAL4 were all obtained from the 
Drosophila stock center (Bloomington, IN). DJ634 was isolated and 
characterized by L. Seroude in our laboratory (Seroude, Brummel et 
al. 2002). We thank Lily and Yuh-Nung Jan for providing us with 
GAL4109(2)80. The Drosophila strain white1118 was used in all control 
crosses and as the background for generation of transgenic lines. 
Male flies were used throughout the study. We screened a publicly 
available collection of insertion lines containing enhancer-promoter 
transposable elements (Rorth collection of EP lines), out of which 
EP(2)2383 was selected for this study. 
 
Lifespans: All crosses were performed at 18ºC to minimize the 
effects of GAL4 during development. For each lifespan experiment 
(all at 29ºC), at least 100 2-4 days old males, were separated from 
females on a Peltier plate maintained at 4ºC to avoid possible 
negative effects of CO2 anesthesia on lifespan. 20-30 flies were put in 
a single vial, transferred every 3-4 days to fresh standard food vials, 
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and the number of dead flies recorded each time. Survival curves 
were analyzed using the Graphpad Prism 4 software, yielding p 
values for a logrank test. 
 
Exposure to hyperoxia: Adult males (2–4 days old) in shell vials 
(20–30 flies per vial) containing standard food were maintained in a 
Plexiglas enclosure of 28 x 28 x 24 inches at room temperature (22–
24°C). Oxygen (100%) was passed through the box at a constant rate 
of 300 ml/min. 
 
Starvation: For each lifespan experiment, at least 100 2-4 days old 
males were separated from females as previously described. 20-30 
flies were put in a single vial, transferred every day to fresh vials, and 
the number of dead flies recorded approximately every 2 hours. For 
dry starvation, the vials contained 5 g of silica gel (desiccant), while 
for wet starvation the vials contained 1% agar, providing water 
throughout the experiment, but no food source. Each experiment was 
repeated at least twice. 
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Generation of transgenic flies: an EST carrying the full GLaz cDNA 
(GH09946) was procured from the DGRC (Indiana, US) and partially 
digested with EcoRI and XhoI. The cDNA fragment was then 
subcloned into the expression vector pUASt, putting the GLaz cDNA 
3’ of a series of five UAS repeats. The purified pUASt-GLaz vector 
was subsequently injected into w1118 embryos, and 2 single-insertion 
lines were selected. Both mapped to the 2nd chromosome. 
 
XGAL staining: 7-day-old adult males were cryosectioned, fixed for 
20 min in 1% glutaraldehyde in PBS (pH 7.2), reacted with 0.1% X-
gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside), and 
incubated at 37C for 4 hours. The reaction was stopped by rinsing 
twice with PBS before mounting in 70% glycerol/PBS. 
 
Dry weight measurement: Flies were raised on standard food for 7 
days at room temperature, then desiccated overnight in a vacuum 
oven at 80°C. Flies were weighed in three groups of 40, and the 
weights are reported as mg dry weight per fly. Each experiment was 
repeated at least twice. 
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Protein content: 40 7-day old males were homogenized in a Potter 
apparatus, in a detergent buffer (10mM Tris, 2mM EDTA, 150mM 
NaCl, 0.15% NP40, protease inhibitors). After a 10 minute spin at 
13,000 rpm, the supernatant was assayed using the BCA (Pierce, IL) 
assay according to manufacturer’s instructions. Amounts are reported 
as mg protein per fly. Each experiment was done in triplicate, and 
repeated at least twice. 
 
Lipid content: 40 7-day old males were desiccated and weighed as 
previously described. They were then submerged in 5 mL of ether for 
24 hours to dissolve lipids. The ether was removed and the remaining 
tissue desiccated and weighed again. The weight difference 
corresponds to the lipid fraction, reported as percentage of dry 
weight. Each experiment was done in triplicate, and repeated at least 
twice. 
 
Behavioral assays before and after hyperoxia: All assays were 
performed at room temperature. Vertical locomotion performance was 
measured by putting 40 flies in a vial, tapping them to the bottom, and 
measuring the percentage of flies that reached the top third of the vial 
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after 10 seconds. Horizontal locomotion performance was measured 
by putting 20 flies in a narrow tube covered in black tape, tapping 
them to one end, with a fiber-optic light at the other end. After 1 
minute, the number of flies having traveled more than 2 inches away 
from the origin was counted and expressed as a percentage of the 
total number. All assays were done in triplicate, and the experiment 
was repeated at least twice. 
 
RT-PCR: Total RNA was extracted from 40 flies of the various 
genotypes using Trizol reagent (Invitrogen, CA). RNA concentration 
was measured using a Nanodrop spectrophotometer, and sample 
concentrations were normalized. The Retroscript kit (Ambion, TX) 
was used according to the manufacturers instruction, using the Oligo-
dT primers provided in the kit. The cDNA was then amplified by PCR 
using two primers specific for GLaz, giving a single 600 bp amplicon 
(F: 5’-ATGATGAGTGGCCAGCCACTT-3’; R: 5’-
GTCGCGGAGCCCCGTAA-3’).  
 
Hypoxia paradigm:  At room temperature, 7-day old adult males 
were placed in 100% N2 for 30 minutes, then brought back to 
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normoxia and allowed to recover for 20 minutes. All flies were awake 
by 20 minutes. 1 hour later, vertical locomotion performance was 
scored, as previously described. 
 
Statistical analyses: All survival curves were analyzed using the 
Prism4 software (Graphpad), and we report mean lifespan +/- SEM. 
The p value given is the result of a logrank test on the Kaplan-Meier 
data. For all other assays (histogram charts), error bars represent 
SEM, and the p values are the result of the Student t test. 
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Chapter 3 
 
Human ApoD, an apolipoprotein upregulated in Alzheimer’s and 
Parkinson’s diseases, extends lifespan and increases stress 
resistance in Drosophila 
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Apolipoprotein D (ApoD) expression increases in several 
neurological disorders, and in spinal cord injury. We provide the 
first report of a physiological role for human ApoD (hApoD): flies 
overexpressing hApoD are long-lived, and protected against 
stress conditions associated with aging and neurodegeneration, 
including hyperoxia, dietary paraquat, and heat stress. We show 
that the fly ortholog, GLaz, is strongly upregulated in response 
to these extrinsic stresses, and also can protect in vitro cultured 
cells in situations modeling Alzheimer’s disease (AD) and 
Parkinson’s disease (PD). In adult flies, hApoD overexpression 
reduces age-associated lipid peroxide accumulation, suggesting 
a proximal mechanism of action. 
In two accompanying papers (see appendix), Ganfornina et 
al. present similar results in mice, while Charron et al. show that 
a plant ortholog of ApoD has similar effects. These data suggest 
that ApoD and its orthologs play an evolutionarily-conserved 
role in response to stress, possibly managing or preventing lipid 
peroxidation. 
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 ApoD is a small, soluble lipid carrier found in most human tissues, 
but especially in glia of the nervous system (Provost, Weech et al. 
1990; Provost, Villeneuve et al. 1991; Weech, Provost et al. 1991; 
Rassart, Bedirian et al. 2000). The protein is highly conserved among 
mammals, and close homologs can also be found in plants and 
bacteria, implying an important basic function. ApoD is elevated in 
many pathological situations, including Alzheimer;s disease (AD), 
Parkinson’s Disease(PD), stroke, schizophrenia, and bipolar disorder 
(Terrisse, Poirier et al. 1998; Kalman, McConathy et al. 2000; 
Thomas, Dean et al. 2001; Sutcliffe and Thomas 2002; Navarro, Del 
Valle et al. 2003; Thomas, Copolov et al. 2003; Rickhag, Deierborg et 
al. 2007). In AD, it can be found in amyloid plaques, within the brains 
of patients (Desai, Ikonomovic et al. 2005). It is upregulated 500-fold 
at the site of sciatic nerve crush injury in the rat (Boyles, Notterpek et 
al. 1990; Boyles, Notterpek et al. 1990). In vitro evidence indicates 
that it can carry membrane lipids, such as arachidonic acid and 
sterols (Morais Cabral, Atkins et al. 1995; Vogt and Skerra 2001; 
Nasreen, Vogt et al. 2006; Eichinger, Nasreen et al. 2007) and may 
be involved in clearance and/or repair of damaged membranes, 
perhaps quenching harmful material released by neurons and glial 
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cells in response to damage, or recruiting lipids to expanding 
membranes. In the etiology of many of the disorders in which ApoD is 
elevated, oxidative stress is thought to play an important part 
(Andersen 2004; Wallace 2005). For example, in AD, -amyloid 
(A42) is known to produce free radicals and hydrogen peroxide, 
which can in turn damage surrounding cells (Butterfield 2002), 
causing an accumulation of lipid peroxides and protein carbonylation 
adducts. Recently, mitochondrial oxidative stress has also been 
implicated in the genesis of hyperphosphorylated tau, another 
canonical feature of AD (Melov, Adlard et al. 2007).  
In an unbiased screen to identify genes that protect Drosophila 
against hyperoxia (100% O2), we discovered that transgenic 
overexpression of a fly ortholog of ApoD, Glial Lazarillo (Glaz), could 
protect against a range of extrinsic stressors, and extend lifespan 
(Walker, Muffat et al. 2006). The relatively high level of homology 
between hApoD and GLaz led us to propose GLaz as a fly model of 
ApoD (Gutierrez, Ganfornina et al. 2000; Sanchez, Ganfornina et al. 
2003)(see Figure S1). We asked whether this effect of GLaz 
overexpression could provide insight into the role of ApoD 
upregulation in neurological disorders, since, to date, no correlation 
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had been established between high ApoD levels and protection 
against degeneration. In the first part of this report, we demonstrate, 
in our transgenic system, that human ApoD (hApoD) can itself protect 
Drosophila under stress conditions relevant to pathological 
processes, and extend lifespan. Overexpression of hApoD also 
reduces the age-related accumulation of lipid peroxides.  
We show that, in adult flies, extrinsic stressors also induce 
GLaz expression, reinforcing the notion that GLaz, the fly ortholog of 
ApoD, is also part of a canonical stress response. Moreover, GLaz 
overexpression in Drosophila S2 cell cultures can protect against  xxx 
A42-induced cytotoxicity, and against paraquat, suggesting that the 
elevation of ApoD in AD or PD may play a role in  salvaging neurons 
under oxidative stress. This study and the accompanying report by 
Ganfornina et al. in the mouse are the first to look at the targeted 
effects of overexpressed hApoD on stress resistance and longevity in 
model organisms. Note that a third accompanying paper by Charron 
et al. describes a similar role for a plant ortholog of ApoD. 
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RESULTS 
 
Generation of hApoD transgenic flies.  
 
We generated two independent lines carrying hApoD cDNA under 
control of GAL4 binding sites (UAS), using a gateway-modified pUASt 
expression vector. In the line UAS-hApoD1, hApoD cDNA is fused 
with Venus Fluorescent Protein (VFP) cDNA at its C-terminus, while 
in UAS-hApoD2, hApoD cDNA is fused with a C-terminal HA 
(influenza hemagglutinin) tag. Both insertions map to the 3rd 
chromosome. In both lines, there is GAL4-dependent increase in the 
amount of hApoD mRNA (Fig. 1A), when driven by the ubiquitous 
driver Daughterless-GAL4 (Da). This mRNA was not detected in 
control flies (w1118, not shown), but there was some weak 
transcription in heterozygous flies lacking the driver. Figure 1B 
displays the green fluorescence (at 485nm) induced by Da on UAS-
hApoD1 (lower panel), confirming that the C-terminus fusion allows 
proper folding of VFP. Da/+ flies are not fluorescent (data not shown) 
while UAS-hApoD1/+ flies have a low background level of 
fluorescence, consistent with the leaky transcription detected  by RT-
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PCR. Figure 1C shows Da/UAS-hApoD2 overexpressing the hApoD-
HA fusion. Staining with an anti-HA primary antibody, followed by a 
FITC-conjugated secondary antibody (lower panel) reveals 
expression of the HA tag in a GAL4-dependent fashion. Although we 
know from the RT-PCR result that some hApoD-HA is transcribed, no 
fluorescent signal was observed in UAS-hApoD2/+ flies (upper 
panel), probably because of the lower detection sensitivity of this 
protocol.  
 
hApoD overexpression extends normal lifespan in Drosophila. 
 
In humans, hApoD is known to be upregulated with age, possibly in 
response to accumulated damage (Kalman, McConathy et al. 2000). 
We used the ubiquitous Da tostronglydrive expression of UAS-hApoD 
transgenes in the whole organism. Using the fact that GAL4 
expression is reduced at lower temperatures (Duffy 2002), expression 
was minimized during early development by raising the larvae and 
pupae at 18C, on standard food (Lewis 1960). Crosses of w1118 to 
either transgene or driver were used as genetic controls and also 
raised at 18C, on standard food. For all genotypes, we raised adult 
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flies on standard food, at 25C, and followed their survival .  Flies 
overexpressing hApoD (Da/UAS-hApoD1) had 40% longer median 
lifespan (Fig. 2A) than the longest-lived control (UAS-hApoD1/w1118).  
For UAS-hApoD2, the median lifespan was increased by 41% (Fig. 
2B). In each case maximum lifespan was also improved. 
 
Overexpression of hApoD protects Drosophila against various 
extrinsic stresses.  
 
We next  exposed the hApoD transgenic flies and their genetic 
controls to 100% oxygen for their entire adult lives, in the paradigm 
originally used to isolate GLaz as a stress-resistance gene. As 
previously shown, such an exposure, for normal flies, results in 
mitochondrial damage consistent with elevated oxidative stress, as 
well as apoptotic muscle degeneration and death within a week 
(Walker and Benzer 2004). This treatment can be considered to be a 
model of accelerated pathological aging. Flies overexpressing UAS-
hApoD1 (Da/UAS-hApoD1) throughout adult life lived on average 
36% longer than the longest-lived control (UAS-hApoD1/+), under 
hyperoxia (Fig. 3A). Da/UAS-hApoD2 flies lived 25% longer than 
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UAS-hApoD2/+ flies (Fig. 3B) under the same conditions. Maximum 
lifespans were also improved significantly. 
Next, we assessed whether hApoD overexpression increases 
resistance to dietary paraquat, which is thought to target complex I of 
the mitochondrial respiratory chain, thereby producing deleterious 
reactive oxygen species. Paraquat has been used to model PD(Peng, 
Stevenson et al. 2005). When hApoD was overexpressed in flies 
exposed  to 20mM paraquat (see Methods),  there was a 40% longer 
median survival on paraquat in Da/UAS-hApoD1 than in their control 
counterparts (Fig. S2A). Similarly Da/UAS-hApoD2 were 38% longer-
lived, on average, than either of their genetic controls (Fig. S2B), 
although maximum lifespans in the population were not affected. 
Heat stress was tested by exposing the flies, in standard food 
vials, to 37C. Da/UAS-hApoD1 flies had a median lifespan 35% 
longer than UAS-hApoD1/+ controls (Fig. S3A), and Da/UAS-hApoD2 
lived on average 40% longer than UAS-hApoD2/+ controls at 37C 
(Fig.S3). In this case, maximum lifespan also increased. All the 
control fly genotypes were dead within 30 hours, while hApoD 
overexpressors survived to the 38-hour mark 
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hApoD overexpression reduces accumulation of lipid peroxides 
in old flies.  
 
Lipid peroxides are formed when free radicals such as superoxide 
produced by  mitochondria, react with membrane and storage lipids 
(Halliwell and Chirico 1993). These lipid peroxides alter the normal 
properties of the membrane, and impair cellular function. Their 
accumulation is a measure of oxidative stress (Toroser, Orr et al. 
2007), and we observed that lipid peroxides normally accumulate in 
wild-type Canton-S (CS) flies over the course of their life (data not 
shown). Here we report that hApoD appears to function, at least in 
part, by constraining lipid peroxides. While control flies display a 
significantly increased lipid peroxide burden between day 4 and day 
40 of adult life, flies overexpressing hApoD1 or hApoD2 clearly 
accumulate less, maintaining the levels of younger flies (Fig. 4). 
These data do not address whether the reduction is at the level of 
generation of lipid peroxides or on their clearance. 
 
Upregulation of the fly ortholog of hApoD, GLaz, by extrinsic 
stress. 
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Given the upregulation of hApoD in various diseases involving 
chronic stress, as in the degeneration seen in stroke, AD or PD, we 
wondered whether individual stresses would also regulate expression 
of the fly ortholog in our model, in situations of acute exposure and 
within a short timeframe.  
Flies lacking GLaz are particularly sensitive to paraquat 
treatment (Sanchez, Lopez-Arias et al. 2006), while flies 
overexpressing GLaz have enhanced resistance (JM unpublished 
data). Paraquat feeding can be viewed as a model of environmentally 
induced neurodegeneration. We compared, by quantitative real-time 
PCR (qRT-PCR), the levels of GLaz mRNA in flies fed paraquat plus 
sucrose to flies fed sucrose only, over the course of 12 hours (Fig. 
5A). Even at the earliest time point of 2 hours, GLaz was dramatically 
upregulated, with a 7-fold induction over its normal level. This 
transcriptional induction decreased gradually but was still upregulated 
3-fold at 12 hours.  
We subsequently performed qRT-PCR on GLaz mRNA on 
young wild type flies (CS) exposed to 100% oxygen, compared with 
flies remaining under normoxic conditions. The transcript abundance 
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of GLaz (Fig. 5B) is stronglyregulated by hyperoxia exposure. 
Remarkably, the GLaz transcript signal rapidly increased 12-fold in 
the first 2 hours, and continued to be elevated 5-fold after 10 hours.  
Given that the heat shock response lies downstream of most 
oxidative stress responses, we also looked at induction of GLaz 
following exposure to high temperature. Flies in standard food vials 
were placed in a 37C incubator. The result in Figure 5C shows that 
GLaz is, once more, a strong responder, with a 4.5-fold upregulation 
at 2 hours, followed by a decline.  
 
Drosophila cells are protected from A42 and paraquat toxicity 
by GLaz overexpression. 
 
As a paradigm in which the beneficial effects of Glaz could be 
monitored more closely, at the cellular level, the effects of transient 
overexpression of GLaz in Drosophila S2 cell cultures were 
examined. We generated constructs allowing expression of HA-
tagged GLaz under an actin promoter. Transfected cells expressed 
the HA-tagged protein (Fig. 6A), secreting it in the culture medium. As 
reported by a co-transfected Blue Fluorescent Protein, the 
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transfection efficiency was 30%. These cells were subsequently 
placed in serum-free medium to avoid interference by bovine 
lipoproteins, and exposed to 10mM paraquat for 24 hours.  After this 
oxidative insult, only 35% of cells transfected with a sham plasmid, 
carrying the actin promoter alone, were still alive, but cells 
overexpressing GLaz were protected, showing no significant cell 
death attributable to this paraquat exposure (Fig. 6B).  
A42 overexpression is sufficient to cause AD-like pathology in 
animal models (Oakley, Cole et al. 2006), and it has been shown that 
A42 can foster the production of the reactive oxygen species 
hydrogen peroxide and superoxide, via Fenton chemistry (Butterfield 
2002). The oligomeric form of A42 is toxic to neurons and glial cells 
in culture. It is thought to be the main cytotoxic species in vivo, and is 
found in the CSF of AD patients (Walsh and Selkoe 2007). ApoD is 
also upregulated in AD and found in the vicinity of plaques (Desai, 
Ikonomovic et al. 2005). Therefore, we wondered whether GLaz 
could protect from A42 cytotoxicity. Transfected Drosophila S2 cells 
were incubated for 24 hours with 1 M A42, pre-aggregated into its 
cytotoxic oligomeric form. Remarkably, we found that overexpression 
of GLaz is indeed protective against A42 cytotoxicity (Fig. 6C). 
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DISCUSSION 
 
These observations are in agreement with a conserved regulation 
and function of ApoD and its homologs under stressful conditions. 
The results obtained with heat stress point to the well-recognized 
overlap in regulation of the oxidative stress response and the heat-
shock pathway (Ahn and Thiele 2003). More studies will be needed to 
establish to what extent the expression of GLaz is under control of 
the heat shock or other stress-inducible pathways.  Since many of the 
pathological situations where ApoD is upregulated in mammals are 
also thought to involve oxidative stress and induction of the heat-
shock pathway, this is an important line of investigation. It is also 
intriguing to ask whether such direct stress responses can be 
observed in a mammalian system as well. The accompanying 
manuscript by Ganfornina et al. indeed shows that, for the mouse, 
ApoD is upregulated when the mice are exposed to paraquat, 
following a similar timecourse as the one we observed for GLaz in the 
fly. In a recent study of mouse ApoD in cultured cells, the authors 
observed induction of mouse ApoD by similar stress conditions (Do 
Carmo, Levros et al. 2007), along with a thought-provoking 
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translocation to the nucleus. The plant ortholog (atTIL) studied in the 
accompanying manuscript by Charron et al. is also induced by 
temperature stress. In a previous study of gene expression changes 
following exposure of Drosophila to hyperoxia (Landis, Abdueva et al. 
2004) alterations in GLaz expression were not found. However, a 
critical difference between that study and ours is that we looked for 
changes following very short exposures to hyperoxia, whereas they 
examined the gene expression after 7 days under hyperoxia.  Note 
that the levels of induction of GLaz observed here are similar to the 7-
fold overexpression we induced in flies using the UAS/GAL4 system 
in a previous study (Walker, Muffat et al. 2006). That overexpression 
was beneficial to the organism over its entire life. The inductions we 
observe occur very early in a process that will eventually lead to 
death, whether by heat or oxidative stress. 
In transgenic flies, we observe a remarkable increase in 
lifespan and multi-stress resistance in human ApoD overexpressors. 
Independently of the results obtained for GLaz, and the homology 
that rooted our interest, these results clearly indicate a beneficial 
function of human ApoD, and may explain its upregulation in various 
disorders. Such an upregulation may limit cumulative processes, 
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typical of age-related disorders, such as lipid peroxidation, protein 
carbonylation, or DNA modifications. This may take effect either by 
accelerating recycling, or by preventing formation of adducts in the 
first place. Other lipocalins have been identified as direct scavengers 
of potentially harmful lipophilic molecules (Lechner, Wojnar et al. 
2001). The accompanying mouse study also puts lipid peroxide 
management in the foreground of protective functions performed by 
ApoD and its homologs. Our results with Drosophila S2 cells support 
the idea that ApoD homologs may also protect cells in acute stress 
situations, providing a possible beneficial role for chronic ApoD 
secretion by astrocytes in the brains of patients with AD or PD, and 
its acute secretion by glia in crushed peripheral nerves. As neurons 
strive to regenerate damaged neurites, glial cells known to express 
ApoD could provide local trophic support, or sequester arachidonic 
acid, thereby tempering inflammation. The non-cell-autonomous 
aspect is exemplified by our cell culture results, where a majority of 
cells are protected, whether they express the transgenes or not. In 
humans, lipoproteins produced outside of the nervous system do not 
pass the blood-brain barrier, therefore it is likely that glial cells would 
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be the most important reservoir of ApoD in stressful conditions, and 
could modulate the levels of this protein in the cerebro-spinal fluid. 
Along with the accompanying mouse study by Ganfornina et al., 
we provide the first evidence that hApoD is more than a neutral 
bystander, let alone a deleterious actor, in pathological situations, in 
animals. Remarkably, the accompanying study by Charron et al. with 
Arabidopsis shows that plant orthologs of ApoD also play a role in 
stress resistance, and may be functionally homologous to the fly and 
mammalian proteins. Taken together, these three reports strongly 
suggest that induction of ApoD might be worthy of investigation as a 
possible therapeutic tool for a range of age-related diseases, 
including Alzheimer’s disease. 
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MATERIALS AND METHODS 
 
Drosophila strains: Da-Gal4 (Da) was obtained from the Drosophila 
stock center (Bloomington, IN). The Drosophila strain white1118 was 
used in all control crosses, as the background for generation of 
transgenic lines, and to outcross (10 times) the driver line Da.  CS 
flies were used as wild type for the GLaz mRNA induction 
experiments. Male flies were used throughout the study. 
 
Histology: Whole flies were frozen in OCT medium and horizontal 
serial 10m cryosections prepared. For VFP detection, the sections 
were immediately mounted in DAPI-glycerol, and imaged using a 
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Zeiss Axioimager with Apotome (10X). For HA detection, the sections 
were fixed in 4% paraformaldehyde, washed in PBS, incubated with a 
rabbit anti-HA primary (1:100) and stained with FITC-conjugated anti-
rabbit (1:250). Control sections were stained with the secondary 
antibody alone. 
 
Lifespans: All crosses, including controls, were performed at 18ºC to 
minimize the effects of GAL4 during development. After eclosion, the 
adults were maintained at 25ºC. For each lifespan experiment, at 
least 100 2 day-old males were separated from females while 
anesthetized in 100% N2. 20-30 flies were put in a single vial 
containing standard food(Lewis 1960), transferred every 3-4 days to a 
fresh vial, and the number of dead flies recorded. Survival curves 
were analyzed using the Graphpad Prism 4 software, yielding p-
values from a logrank test. 
 
Exposure to hyperoxia: 2-day old adult males, 20–30 flies per vial 
containing standard food, were maintained in a Plexiglas enclosure of 
28 x 28 x 24 inches at room temperature (22–24°C). Oxygen (100%) 
was passed through the box at a constant rate of 300 ml/min. 
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Paraquat feeding: For each experiment, at least 100 2-day old flies, 
at 20-30 flies per vial, were transferred daily to fresh medium, and the 
number of dead flies recorded approximately every 2 hours. For 
controls, the vials contained 5 mL of 1% agar, 5% sucrose, while 
paraquat vials contained the same food with 20mM paraquat added. 
 
Generation of transgenic flies: hApoD cDNA was kindly provided 
by Elizabeth Thomas and J. Gregor Sutcliffe (U.C. San Diego) in a 
pcDNA3.1 vector, and amplified by PCR. The cDNA was then 
subcloned into an entry vector for the Gateway system (Invitrogen, 
CA) using the TOPO system. Following the manufacturer’s 
instructions, the cDNA fragments were recombined into a modified 
pUASt vector (Murphy Lab, Carnegie Institution), putting the hApoD 
cDNA (without STOP codon) 3’ of UAS repeats, in frame with the HA 
tag motif, or with the VFP sequence. The purified vectors were 
sequence-verified, injected into w1118 embryos, and w+ transformants 
selected and mapped. 
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qRT-PCR and RT-PCR: Total RNA was extracted from 40 wild-type 
flies (CS) using Trizol reagent (Invitrogen, CA). RNA concentration 
was measured with a Nanodrop spectrophotometer, and sample 
concentrations normalized. The Retroscript kit (Ambion, TX) was 
used according to manufacturer’s instructions, using Oligo-dT 
primers. For RT-PCR of hApoD and actin, primers were designed and 
the products were run on a 0.8% agarose gel. For qRT-PCR of GLaz, 
total cDNA from CS flies exposed to the various test conditions was 
amplified using a set of primers specific for GLaz, giving 100 bp 
amplicon spanning the first intron-exon boundary of the gene. The 
controls were rp49 and TBP, used to normalize the cDNA amounts. 
SYBR green mix (Biorad, CA) was used to monitor DNA amount 
during the PCR for 40 cycles, using an iQ5 thermal cycler (Biorad). A 
fluorescence threshold was chosen in the linear portion of the 
amplification reaction, and the cycle number (Ct) needed to cross that 
threshold was recorded for each sample. Analysis of GLaz and 
control gene values stressed and in normal conditions yielded the 
Ct values. Using the Pfaffl method (Pfaffl 2001), with pre-
calculated primer efficiencies, the Ct values were converted to 
mRNA fold changes. Melting curves were established for all 
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conditions to check that no abnormal secondary structures were 
forming during the PCR reactions. 
 
Cell culture: S2 cells were maintained as adherent cultures at room 
temperature in Schneider’s medium supplemented with 10% FBS. 
For viability experiments, cells were transfected with either a sham 
pAHW plasmid (Murphy lab) containing the actin promoter and 
gateway cassette alone, or pAHW in which  the Glaz cDNA had been 
subcloned using gateway recombination, fusing the protein with a C-
terminal 3xHA tag. Transfection was performed with the Fugene HD 
(Roche, PA) reagent in a 9:2 ratio, per the manufacturer’s 
instructions. All plasmids were co-transfected with pAc-BFP (blue 
fluorescent protein) to assess transfection efficiency. Cells were 
allowed to recover and express for 48 hours, before paraquat or A42 
were added to serum free medium at respective final concentrations 
of 10mM and 1uM. Viability was assessed using the live/dead assay 
(Invitrogen, CA), per the manufacturer’s instruction. Live cells 
appeared green under a fluorescence microscope (Zeiss axioimager 
Z1), while dead cells appeared red. Experiments were done in 96 well 
plates, in experimental triplicates. Counting was done on aliquots of 
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each experimental well by an experimenter blind to the assay 
conditions. Results were expressed as percentage of cells alive after 
transfection and treatment. 
 
Lipid peroxidation assay: we used the LPO-586 assay (Oxis 
research, Portland, OR) per the manufacturer’s instruction.  Each 
sample consisted of 50 flies of each genotype and age, in triplicates. 
Flies were homogenized in PBS with added butylated hydroxy-
toluene (preventing additional lipid peroxidation during sample 
preparation). After centrifuging insoluble components (10 min, 
13000g), the clear supernatant was incubated with the assay 
reagents, and a blank was prepared incubating the same sample with 
acetonitrile instead. Again the incubated samples were spun down, 
and triplicate 250uL-aliquots of each sample were loaded onto a 96-
well plate. Absorbance was read at 586nm. Absorbance values of the 
blanks were subtracted from each sample value. A standard provided 
by the manufacturer was used to generate a standard curve and give 
a nanomolar concentration of malonyldialedhyde (MDA) and 4-
hydroxynonenal (4-HNE) corresponding to the absorbances. All 
amounts were subsequently normalized to protein concentrations of 
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each sample established using a Bradford assay (Biorad, CA), 
yielding values in nanomoles per milligram of total protein. 
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Figure 1:  Generation of two human ApoD (hApoD) transgenic 
lines, using the UAS/GAL4 system. 
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 A: RT-PCR shows hApoD driven by Da in each strain compared to 
control strains. B: Horizontal cryosection through Da/UAS-hApoD1, 
shows strong, ubiquitous green VFP signal (the red color is due to 
cuticle autofluorescence). Normal signal is seen in UAS-hApoD1/+ 
control flies. C: Horizontal cryosection through Da/UAS-hApoD2 
which carries the HA-tag. Green fluorescence (FITC) reveals the 
presence of hApoD, stained by HA antibody, in most tissues (less 
intense than the VFP marker). 
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Figure 2: Overexpression of human ApoD extends normal 
lifespan of Drosophila. 
 
Survival was recorded on standard food, in normoxia, at 25C. A: 
Da/UAS-hApoD1 flies had a 40% longer median lifespan than UAS-
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hApoD1/+ controls (p<0.001). Maximum lifespan was also improved 
by 20%. B: Da/UAS-hApoD2 flies had a 41% longer median lifespan 
than UAS-hApoD2/+ controls (p<0.001). Maximum lifespan was also 
improved by 19%. 
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Figure 3: Overexpression of hApoD protects  against hyperoxia, 
in Drosophila. 
 
Survival was recorded on standard food, in 100% oxygen, at 25C. A: 
Da/UAS-hApoD1 flies had a 25% longer median lifespan than UAS-
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hApoD1/+ controls (p<0.001). Maximum survival was also improved 
by 20%. B: Da/UAS-hApoD2 flies had a 20% longer median survival 
than UAS-hApoD2/+ controls (p<0.001). Maximum survival was also 
improved by 15%. 
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Figure 4: hApoD overexpression reduces lipid peroxide 
accumulation in old Drosophila.  
 
Adult flies were maintained on standard food at 25C. A: Da/UAS-
hApoD1 flies did not display any significant increase in lipid peroxide 
burden at 40 days of age, while control flies saw this burden increase 
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2-fold during the same period (*** p<0.005, t-test). B: similar results 
were found with the Da/UAS-hApoD2 flies, compared to controls (*** 
p<0.005, t-test). 
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Figure 5: Induction of GLaz mRNA in wild-type flies (CS), by 
extrinsic stress. 
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Data represent fold increase in GLaz mRNA levels, compared to flies 
in control conditions, assessed by qRT-PCR (t=0, normoxia, standard 
food). A: On 5% sucrose/20mM paraquat, demonstrating a dramatic 
upregulation of GLaz mRNA. Induction peaked  at 7-fold after 2 hours 
and decreased back to 3-fold after 12 hours. (control: t=0, no 
paraquat). B:  In 100% oxygen, on standard fly food. GLaz mRNA 
induction peaked at 12-fold after 2 hours and stabilized at 6-fold after 
10 hours. C: At 37C, on standard fly food. GLaz mRNA was induced 
4.5-fold at 2 hours, and remained upregulated 2-fold after 4 hours. 
During the time frame of each experiment, no death occurred. All 
values were normalized using housekeeping genes rp49 and TBP as 
references (see methods). Values are averages of 3 independent 
experiments +/- SEM. A Student t-test performed on the Ct values 
yielded p-values (*** p<0.005). 
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Figure 6: GLaz protects Drosophila S2 cells against death 
induced by paraquat and A42.  
 
A: anti-HA western blot showing that GLaz-HA is expressed under 
the actin promoter in Drosophila S2 cells and secreted into the 
medium. B: S2 cells were transfected for 48 hours, then exposed to 
10mM paraquat or 1uM A42 for 24 hours, and assayed for viability. 
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Cells transfected with a control plamid (actin promoter alone, pAc) 
showed low survival when exposed to paraquat or A42 (respectively 
35% and 53%). GLaz overexpression by pAc-GLaz was sufficient to 
protect the cells against the stress of both paraquat and A42 
(respectively 94% and 95% viability after 24 hours, *** p<0.005, t-
test). 
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SUPPLEMENTARY FIGURES: 
 
 
Figure S1: Alignment of human ApoD and GLaz.  
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ClustalW alignment of human Apolipoprotein D and the  Drosophila 
ortholog GLaz. Both proteins are lipocalins, lipid carriers 
characterized by a chalice structure formed by 8 β-sheets (shown 
here as grey arrows). These proteins show significant homology, 
especially in 3 Structurally Conserved Regions (SCR1, 2 and 3), 
considered to be the backbone of the structure. In this case, the 
overall identity reaches 35%, while the SCRs (red, green and blue 
boxes) all show more than 50% identity. When amino-acid properties 
are taken into account, the SCRs display more than 70% similarity. 
The grey box represents the signal peptides (SP), while the yellow 
box denotes another region of significant homology not found in other 
lipocalins. 
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Figure S2:  overexpression of human ApoD enhances resistance 
to paraquat, in Drosophila. 
 
A: Effect of overexpressing UAS-hApoD1, using Da as a ubiquitous 
driver. Survival was recorded on 5% sucrose, 1% agar, at 25C, with 
20mM paraquat added. Da/UAS-hApoD1 flies had a 40% longer 
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median survival than UAS-hApoD1/+ controls (p<0.001). B: Da/UAS-
hApoD2 flies had a 38% longer median survival than UAS-hApoD2/+ 
controls (p<0.001). 
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Figure S3: Overexpression of hApoD increases resistance to 
heat, in Drosophila 
 
Survival was recorded on normal food, at 37C. A: Da/UAS-hApoD1 
flies had a 35% longer median survival than UAS-hApoD1/+ controls 
(p<0.001). Maximum survival was also improved by 25% (p<0.001). 
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B: Da/UAS-hApoD2 flies had a 40% longer median survival than 
UAS-hApoD2/+ controls (p<0.001). Maximum survival was also 
improved by 26%. 
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Chapter 4 
 
Control of metabolic homeostasis by stress signaling is 
mediated by the Lipocalin NLaz 
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Metabolic homeostasis in metazoans is regulated by endocrine 
interactions between different insulin target tissues. Adipose-
secreted factors, such as adipokines and lipocalins, are 
emerging as central regulators of peripheral insulin sensitivity 
and have been implicated in metabolic diseases, most 
prominently type II diabetes. Insulin resistance, a hallmark of 
type II diabetes, is caused in part by adipose-specific activation 
of stress and inflammatory signaling pathways, such as Jun-N-
terminal Kinase (JNK) signaling. Chronic activation of JNK in 
adipose tissue of obese animals induces systemic insulin 
resistance, but the physiological role of this interaction between 
JNK and Insulin signaling remains unclear. JNK also causes 
systemic insulin resistance in invertebrates, promoting stress 
tolerance and extending lifespan, and suggesting that the 
interaction between JNK and insulin signaling is an 
evolutionarily conserved adaptive response of the organism that 
allows managing energy resources under stress conditions. 
Here we show that JNK signaling is required for metabolic 
homeostasis in flies, influencing nutrient storage, glucose 
127 
 
homeostasis and starvation tolerance. We find that this function 
is mediated by the Drosophila Lipocalin family member Neural 
Lazarillo (NLaz), a homologue of vertebrate Apolipoprotein D 
(ApoD) and Retinol Binding Protein 4 (RBP4), which is 
transcriptionally regulated by JNK signaling. Nlaz is required for 
JNK-mediated stress and starvation tolerance, and its over-
expression represses growth, promotes stress tolerance and 
extends lifespan, phenotypes that are consistent with reduced 
insulin signaling activity. Accordingly, we find elevated levels of 
Insulin signaling activity in NLaz mutant flies. Our results 
indicate that the regulation of NLaz by JNK signaling is central 
to the metabolic adaptation of the organism to stress. 
 
Introduction 
 
System-wide coordination of cellular energy consumption and storage 
is crucial to maintain metabolic homeostasis in multicellular 
organisms. It is becoming increasingly apparent that endocrine 
mechanisms that are required for this coordination impact the long-
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term health of adult animals and significantly influence lifespan and 
environmental stress tolerance (Kloting and Bluher 2005; Kahn, Hull 
et al. 2006; Russell and Kahn 2007).  Insulin/IGF signaling (IIS) is 
central to this regulation, as loss of Insulin signaling activity impairs 
metabolic homeostasis, but induces stress tolerance and increases 
lifespan in a variety of model organisms (Kloting and Bluher 2005; 
Kahn, Hull et al. 2006; Russell and Kahn 2007). Interestingly, 
environmental stress and cellular damage can systemically repress 
IIS activity, suggesting the existence of adaptive response 
mechanisms by which metazoans manage energy resources in times 
of need (Tatar and Yin 2001; Wang, Bohmann et al. 2005; 
Baumeister, Schaffitzel et al. 2006; Niedernhofer, Garinis et al. 2006; 
van der Pluijm, Garinis et al. 2007). The mechanism(s) and mediators 
of this endocrine regulatory system are only beginning to be 
understood (Kloting and Bluher 2005; Hotamisligil 2006; Kahn, Hull et 
al. 2006; Russell and Kahn 2007).  
Studies in flies and worms have recently identified the stress-
responsive Jun-N-terminal Kinase (JNK) signaling pathway as an 
important component of such an adaptive metabolic response to 
stress. JNK activation, which can be induced by a variety of 
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environmental stressors, including oxidative stress, represses IIS 
activity, extending lifespan but limiting growth (Oh, Mukhopadhyay et 
al. 2005; Wang, Bohmann et al. 2005). Interestingly, similar effects of 
JNK signaling are also observed in mammals, in which it represses 
Insulin signal transduction by various mechanisms, including an 
inhibitory phosphorylation of Ser-307 of the insulin receptor substrate, 
as well as activation of the transcription factor FoxO (Aguirre, Uchida 
et al. 2000; Essers, Weijzen et al. 2004). This inhibition contributes to 
Insulin resistance and the metabolic syndrome in obese mice 
(Hirosumi, Tuncman et al. 2002), suggesting that chronic 
inflammatory processes (which result in activation of JNK signaling) 
are central to the etiology of metabolic diseases in obese individuals 
(Hotamisligil 2006).  
Endocrine interactions between Insulin-producing and various Insulin-
responsive tissues are likely to coordinate the adaptive metabolic 
response described above (Kloting and Bluher 2005; Kahn, Hull et al. 
2006; Russell and Kahn 2007). JNK-mediated activation of Foxo in 
Insulin Producing Cells (IPCs) of flies, for example, represses the 
expression of insulin-like peptide 2 (dilp2), regulating growth and 
longevity (Wang et al., 2005). At the same time, Foxo activation in the 
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fatbody results in lifespan extension, presumably by an endocrine 
mechanism that feeds back to IPCs (Giannakou, Goss et al. 2004; 
Hwangbo, Gersham et al. 2004).   
Adipose tissue is increasingly being recognized as an important 
regulator of metabolic homeostasis. It secretes a variety of so-called 
adipokines, including the inflammatory cytokine TNF-alpha 
(Hotamisligil 2006). TNF-alpha activates JNK signaling, contributing 
to JNK-mediated insulin resistance in mouse models for obesity 
(Hirosumi, Tuncman et al. 2002; Hotamisligil 2006). While the chronic 
inhibition of insulin signaling by adipose-derived TNFalpha thus has 
deleterious effects in obese individuals, it is likely that such endocrine 
interactions have evolved to govern metabolic homeostasis 
systemically in an adaptive manner (Hotamisligil 2006). Supporting 
this view, adipose tissue is an important regulator of lifespan in 
worms, flies, and mice, and it is emerging that systemic inhibition of 
Insulin signaling by adipose-derived factors is involved in this effect 
(Kloting and Bluher 2005; Kahn, Hull et al. 2006; Russell and Kahn 
2007).  
An endocrine role for adipose tissue in metabolic regulation has 
further been demonstrated in mice with adipose-specific deletion of 
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the glucose transporter GLUT4, in which secretion of the Lipocalin 
family member RBP4 from fat cells induces insulin resistance 
throughout the organism (Abel, Peroni et al. 2001; Yang, Graham et 
al. 2005). Such an endocrine system is expected to be adaptive, 
since it preserves glucose for only the most essential functions during 
starvation or environmental stress. At the same time, mis-regulation 
of this system is likely to contribute to metabolic diseases like type II 
diabetes. Accordingly, increased serum levels of RBP4 are found in 
obese and diabetic individuals (Graham, Yang et al. 2006), and 
polymorphisms in the rbp4 locus are associated with type II diabetes 
(Munkhtulga, Nakayama et al. 2006).  
The Lipocalins are a large family of secreted proteins that bind 
small hydrophobic ligands (Flower 1996)(Åkerström et al., 2006). 
Lipocalin family members are characterized by a low sequence 
similarity (reflecting diversification of biological functions), but a highly 
conserved tertiary protein structure and similar arrangement of exons 
and introns in the coding sequence of their genes (Sanchez et al., 
2006b; Sanchez, Ganfornina et al. 2003). Recent studies implicate 
various Lipocalins as regulators of systemic insulin action and of 
stress responses (Yang, Graham et al. 2005; van Dam and Hu 2007; 
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Yan, Yang et al. 2007; Ganfornina, Do Carmo et al. 2008; Muffat, 
Walker et al. 2008). The Drosophila genome contains three Lipocalin 
genes: NLaz, GLaz, and karl. Recent studies have identified an 
important role for GLaz in metabolic regulation, stress tolerance and 
lifespan control (Sanchez, Lopez-Arias et al. 2006; Walker, Muffat et 
al. 2006). While the function of NLaz remains unclear, in situ 
hybridization in Drosophila embryos suggest that it is expressed in a 
subset of neuronal cells, and, interestingly, in the developing fat body 
(Sanchez, Ganfornina et al. 2000). 
Here, we show that NLaz transcription is induced by JNK 
signaling and in response to oxidative stress, influencing metabolic 
homeostasis in the fly. Importantly, NLaz induces stress and 
starvation tolerance downstream of JNK signaling, and negatively 
regulates Insulin signaling, disrupting glucose homeostasis, 
repressing growth, and extending lifespan. Our results thus indicate 
that NLaz is part of a stress response mechanism in flies that adjusts 
metabolism and growth in response to environmental insults. 
Results 
JNK signaling is required for metabolic homeostasis in flies. 
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 Based on the ability of JNK signaling to antagonize IIS activity 
in flies and worms (Oh, Mukhopadhyay et al. 2005, Wang, 2005 
#957; Wang, Bohmann et al. 2005), and on the starvation tolerance 
of flies with increased JNK signaling activity (Wang et al., 2003), we 
hypothesized that this pathway plays a role in regulating metabolic 
homeostasis under physiological conditions. To start characterizing 
such a role, we analyzed the maintenance of nutrient stores under 
starvation conditions in wild-type flies and in flies mutant for the JNK 
activating Kinase Hemipterous (JNKK/Hep). Interestingly, males 
hemizygous for the hep loss-of-function allele hep1 exhibited 
significantly reduced energy stores (lipids and carbohydrates) in ad 
libitum conditions compared to wild-type control flies, suggesting 
impaired metabolic homeostasis in these animals (Figure 1 A-C, 
Figure S1). Accordingly, we found that in hep1 mutants, nutrient 
stores were rapidly depleted upon starvation. Interestingly, hep1 
mutants also exhibited an accelerated and increased gluconeogenic 
response to starvation (Figure 1 D), measured by 
phosphoenolpyruvat carboxykinase (PEPCK) expression (Zinke, 
Kirchner et al. 1999), supporting the idea that JNK signaling mutants 
suffer a rapid decline in available free sugars upon starvation. 
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Consistent with this view, hep1 hemizygotes are significantly more 
sensitive to starvation than wild-type controls (Figure 1 E). Similarly, 
flies in which JNK signaling was repressed by ubiquitous over-
expression of a dsRNA against the Drosophila JNK Basket (Bsk) 
were sensitive to starvation, confirming a loss of metabolic 
homeostasis in JNK loss-of-function conditions (Figure 1 F). 
Interestingly, these findings recapitulate similar observations in IIS 
gain-of-function conditions, which lead to a decrease in steady-state 
metabolic stores and starvation sensitivity, as well as IIS loss-of-
function conditions, which show the opposite results (Bohni, Riesgo-
Escovar et al. 1999; Clancy, Gems et al. 2001; Oldham, Stocker et al. 
2002; Rulifson, Kim et al. 2002; Broughton, Piper et al. 2005). The 
effects of JNK signaling on metabolism thus support the perceived 
antagonism between JNK signaling and IIS in the regulation of 
energy homeostasis (Oh, Mukhopadhyay et al. 2005, Wang, 2005 
#957; Wang, Bohmann et al. 2005). Since we had previously found 
that JNK represses dilp2 transcription in IPCs in response to 
oxidative stress (Wang et al., 2005 and Hull-Thompson et al., in 
preparation), we tested whether the starvation sensitivity in hep1 
mutants correlates with elevated dilp2 transcription. Surprisingly, we 
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found no difference in dilp2 (nor dilp3 or dilp5) transcript levels in 
hep1 mutants compared to wild-type controls under ad libitum 
conditions, and no changes in dilp2 transcription in response to 
starvation (Figure S1B and data not shown; dilp2 transcript levels are 
insensitive to nutritional conditions, see (Gershman, Puig et al. 
2007)). These results suggest that, while JNK regulates dilp2 
transcription to regulate systemic responses to stress, other targets of 
JNK might be mediating the control of metabolic homeostasis. Since 
mammalian JNK acts in adipose tissue to induce Insulin resistance, 
we focused on the fatbody as a potential site of action for JNK in flies.   
To identify potential mediators of JNK-induced metabolic changes, 
we tested the transcriptional response of a number of candidate 
genes to JNK activation. We focused on the putative adipokines and 
secreted regulators of Insulin signaling, dALS, IMP-L2, GLaz, Karl, 
and NLaz, since these molecules and their mammalian homologues 
have been implicated in systemically governing metabolic 
homeostasis. Activation of JNK was achieved by over-expression of a 
constitutively active Hep (Hepact) in larvae using the TARGET system, 
which allows heat-inducible expression of UAS-linked transgenes 
(McGuire, Le et al. 2003). We expressed Hepact ubiquitously (using 
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the ubiquitous driver T80-Gal4), or specifically in the fatbody (using 
the fatbody driver ppl-Gal4, (Zinke, Kirchner et al. 1999)), for a short 
period of time, increasing the likelihood of observing direct 
transcriptional effects of increased JNK activity. Transcript levels of 
potential JNK target genes were then assessed by real-time RT-PCR 
(Figure 2 and Figure S1C). 
Among the tested molecules, we found that transcription of the 
Lipocalin NLaz was potently induced in the fatbody in response to 
JNK activation, within a timeframe that resembles the induction of 
puc, a bona fide JNK signaling target gene (Figure 2). Another 
Lipocalin, Karl, was also induced by JNK signaling, albeit to a lesser 
extent (Figure S1C).  
NLaz acts downtream of JNK to maintain metabolic homeostasis. 
These results, and the known effects of the NLaz homologue Rbp4 in 
mice, suggested that NLaz or Karl might act downstream of JNK 
signaling to regulate metabolic homeostasis. To test this hypothesis, 
we measured carbohydrate and lipid levels in homozygous NLaz 
mutant flies (using the knock-out allele NLazNW5, derived from the 
NLazSceI allele (Rong, Titen et al. 2002)) and isogenic controls. 
Similar to hep1 mutants, NLaz mutants exhibited reduced stores and 
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rapid starvation-induced decline of glucose, trehalose, glycogen, and 
triglyceride levels (Figure 3A–C and Figure S1D). Likewise, NLaz 
mutants showed an accelerated gluconeogenic response (induction 
of PEPCK, (Zinke, Kirchner et al. 1999)) and were sensitive to 
starvation (Figure 3D, E).  
Since NLaz is expressed in the fatbody (Sanchez, Ganfornina et al. 
2000), we tested whether NLaz or Karl over-expression in the fatbody 
would be sufficient to protect the organism from starvation sensitivity. 
Indeed, we found that expression of NLaz using ppl-Gal4 promotes 
starvation tolerance (Figure 3 F). Expression of Karl, on the other 
hand, did not protect against starvation (Figure S2A). 
These results suggested that JNK-mediated induction of NLaz in the 
fatbody regulates metabolic homeostasis. Supporting this view, we 
found that fatbody expression of NLaz was sufficient to restore 
starvation tolerance and Glucose and Triglyceride levels in hep1 
mutants (Figure 4). Since NLaz is secreted (see Sanchez et al., 2000, 
and Figure S6), it is impossible to rule out that NLaz induction in other 
tissues also contributes to metabolic homeostasis. Indeed, when 
expressed in pericardial cells and hemocytes of flies (using the 
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dorothy-Gal4 driver, dot-Gal4 (Kimbrell, Hice et al. 2002)), NLaz also 
protects against starvation (Figure S2B).  
NLaz promotes stress tolerance. 
JNK signaling promotes oxidative stress tolerance of flies and worms. 
Similarly, reduced IIS activity also leads to stress tolerance, and the 
known crosstalk between these two pathways indicates that 
metabolic and stress responses are tightly linked, allowing organisms 
to balance protective and growth responses in accordance with 
available resources (Kloting and Bluher 2005; Kahn, Hull et al. 2006; 
Russell and Kahn 2007). Based on these studies and on our findings 
described above, we reasoned that NLaz-mediated metabolic 
changes can influence stress tolerance of flies. To test this 
hypothesis, we first assessed whether NLaz transcription would be 
induced in response to oxidative stress, and found that NLaz 
expression is indeed elevated in flies exposed to the reactive-oxygen 
inducing compound Paraquat (resembling the induction of puc; Figure 
5 A). We further tested stress sensitivity of NLaz mutants, and found 
that these flies exhibit increased sensitivity to Paraquat compared to 
wild-type control flies (Figure 5 B). Over-expression of NLaz both 
ubiquitously and in the fatbody, on the other hand, confers resistance 
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to Paraquat as well as hyperoxic conditions, supporting a protective 
role for NLaz in the fly (Figure 5C and Figure S3). To test whether 
this function of NLaz was specific for oxidative stress, we assessed 
the sensitivity of NLaz over-expressing flies to infection with 
Enterococcus faecalis. E. faecalis infection is lethal to flies, and JNK 
promotes resistance against it (Libert, Chao et al. 2008). Interestingly, 
NLaz over-expression in hemocytes (which mediate immune 
responses in flies; (Agaisse, Petersen et al. 2003; Lemaitre and 
Hoffmann 2007)) was not sufficient to induce infection tolerance, 
suggesting that NLaz acts specifically to protect against oxidative 
stress (Figure S3C). Karl expression in hemocytes, on the other 
hand, is both sufficient and required for infection tolerance, 
suggesting that these two Lipocalins mediate specific stress 
responses downstream of JNK signaling (Figure S3D). Further 
studies will be needed to confirm a role for Karl downstream of JNK in 
this context. 
JNK activity in the fatbody confers NLaz-dependent stress tolerance. 
Stress protection by JNK signaling has been observed in pucE69 
mutants, which exhibit elevated JNK signaling throughout the 
organism (Wang et al., 2003), but also in flies over-expressing 
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JNKK/Hep in neuronal tissue exclusively. This suggests that secreted 
molecules promote stress tolerance downstream of JNK signaling 
(Oh, Mukhopadhyay et al. 2005, Wang, 2005 #957; Wang, Bohmann 
et al. 2005). One endocrine mechanism by which JNK activity 
promotes stress tolerance is downregulation of dilp2 expression in 
IPCs (Wang et al., 2005, Hull-Thompson et al., in preparation). 
Interestingly, however, increased stress tolerance can also be 
observed when JNKK/Hep is specifically over-expressed in the 
fatbody (Figure 5 D). To test whether NLaz induction might mediate 
the endocrine effects of fatbody-specific JNK activation, we assessed 
stress tolerance of NLaz mutant flies in which JNKK/Hep was over-
expressed in the fatbody. Remarkably, we found that lack of NLaz 
completely abolished the ability of JNKK/Hep expression to promote 
stress tolerance (Figure 5 D). These results indicate that Nlaz 
induction is an integral component of the JNK-mediated adaptation to 
environmental stress in Drosophila.  
NLaz promotes longevity.  
Our results thus support a model in which Nlaz is required 
downstream of JNK signaling to promote metabolic homeostasis and 
stress tolerance. Since elevated JNK signaling is associated with 
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increased longevity in the fly, we tested the effect of NLaz on 
lifespan. Consistent with our other findings, flies lacking NLaz 
function are short-lived relative to isogenic controls (Figure 5E), while 
over-expression of NLaz with a ubiquitous driver increases lifespan 
(Figure 5F and Figure S5). These results further support the view that 
the effects of NLaz on metabolic homeostasis and stress tolerance 
are an important adaptive mechanism to preserve energy resources 
and optimize the fitness of the organism.  
NLaz represses growth and affects hemolymph glucose levels. 
Interestingly, the phenotypes we observed in flies over-expressing 
Nlaz (starvation tolerance, stress resistance and extended lifespan) 
are also phenotypes associated with reduced IIS activity in the fly 
(Clancy, Gems et al. 2001; Rulifson, Kim et al. 2002; Broughton, 
Piper et al. 2005), suggesting that the effects of NLaz might be 
mediated by inhibition of IIS.  
To test this notion, we asked whether NLaz would affect other IIS-
regulated processes in the fly. Indeed, we found elevated membrane 
localization of the reporter for PI3K activity, GFP-PH, in fatbody cells 
of NLaz mutant flies, suggesting that Insulin signaling is increased in 
these cells in the absence of NLaz (Figure 6 A-C; PI3K activity is 
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indicative of Insulin signaling activity in flies and GFP-PH is widely 
used as a reliable reporter for this activity (Britton, Lockwood et al. 
2002)). Further supporting a role for NLaz in repressing Insulin 
signaling, increased expression of NLaz in the fatbody also leads to 
elevated hemolymph glucose levels in third-instar larvae (Figure 6 D), 
a phenotype that is associated with reduced IIS activity and that is 
reminiscent of defects in Glucose homeostasis observed in Insulin 
resistant vertebrates (Rulifson, Kim et al. 2002). In addition, we found 
that over-expression of NLaz could not further promote starvation 
tolerance of heterozygotes for the chico loss-of-function allele chico1 
(Figure 6E; Chico is the Drosophila homologue of Insulin receptor 
substrates (Bohni, Riesgo-Escovar et al. 1999; Clancy, Gems et al. 
2001)). Furthermore, over-expression of NLaz in the fatbody reduces 
growth of the animal (measured as fresh weight as well as wing size) 
in a heterozygous NLaz mutant background (Figure 6 F-H), and NLaz 
over-expression induces the expression of the Foxo target gene 
l(2)efl in larvae (Figure S4A). Supporting the view that NLaz acts 
upstream of IIS in metabolic regulation, we did not observe changes 
in NLaz expression in chico1 heterozygous animals (Figure S4B). 
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Taken together, these results support the notion that NLaz represses 
Insulin signaling systemically. Interestingly, however, transcript levels 
of the three major insulin-like peptides dilp2, dilp3, and dilp5, were 
unaffected by NLaz loss-or gain-of-function conditions, and by over-
expression of Hep in the fatbody (Figure S4C, D), indicating that the 
repression of IIS by NLaz is not mediated by regulation of dilp 
transcription, but by downstream events that promote insulin 
resistance.   
 
Discussion 
 
Our findings support a role for JNK – mediated NLaz induction in the 
fatbody as a central part of an adaptive endocrine system that 
coordinates metabolism in response to environmental stress (Figure 
6). Recent studies have highlighted the role of adipose-derived 
endocrine factors in such adaptive responses (Hotamisligil 2006; 
Russell and Kahn 2007). For example, over-expression of the 
transcription factor dFoxo in the Drosophila fatbody leads to lifespan 
extension and stress tolerance, presumably mediated by systemic 
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repression of IIS (Giannakou, Goss et al. 2004; Hwangbo, Gersham 
et al. 2004). Similar effects of adipose-specific activation of Foxo 
have been observed in C.elegans and mice (Bluher, Kahn et al. 2003; 
Libina, Berman et al. 2003). Additionally, amino acid deprivation of 
the Drosophila fat body leads to marked decreases in PI3K activity in 
wing imaginal discs and in the epidermis (Colombani, Raisin et al. 
2003). While it is unclear what factors mediate this systemic 
repression of IIS by adipose-specific Foxo activity, our studies 
implicate NLaz as a potential candidate.  
Interestingly, our studies indicate that JNK-mediated repression of IIS 
in flies is not only mediated by its function in IPCs (where it represses 
dilp2 transcription; Wang et al., 2005; Hull-Thompson et al., in 
preparation), but that JNK activity in adipose tissue separately 
regulates Insulin resistance through NLaz induction. This dual 
function of JNK is intriguing, as it indicates that adaptive regulation of 
metabolism requires coordinated control of both Insulin-like peptide 
production and Insulin sensitivity of Insulin target tissues. How the 
relative contribution of these effects regulates the organism’s 
metabolic homeostasis, stress resistance and lifespan, is an 
intriguing question that will require further investigation. 
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Recent reports, and our results presented here further indicate that 
Lipocalins have a conserved role in the control of stress tolerance 
and metabolic homeostasis. Vertebrate Lipocalins are important 
modulators of insulin action in mammals, and recent studies suggest 
a protective role of these molecules (Yang, Graham et al. 2005; Yan, 
Yang et al. 2007; Ganfornina, Do Carmo et al. 2008; Muffat, Walker 
et al. 2008). Our finding that NLaz promotes stress and starvation 
tolerance downstream of JNK signaling by repressing IIS activity, 
predicts that similar functions are conserved in mammalian 
homologues and has important implications for potential therapeutic 
targeting of these molecules. Interestingly, our results suggest 
functional specificity between different Lipocalins. While NLaz and 
GLaz both regulate stress sensitivity, only NLaz was found to be 
regulated by JNK signaling. Regulation of Karl, on the other hand, 
does not influence oxidative stress resistance or starvation tolerance, 
but promotes resistance against infection. Further investigation of this 
intriguing diversification of Lipocalin function promises to provide 
important insight into the systemic regulation of adaptation to 
environmental challenges.     
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In humans, dysregulation of Lipocalins has been correlated with 
obesity, insulin resistance, and type II diabetes (Yang, Graham et al. 
2005; van Dam and Hu 2007; Wang, Lam et al. 2007). The cause for 
this mis-regulation remains unclear, however. Our results implicate 
the evolutionarily conserved JNK signaling pathway, which is 
activated chronically in obese conditions, as a possible cause. The 
finding that mammalian lipocalin-2, which impairs insulin action, is 
induced by the JNK activator TNFalpha, is especially intriquing (Yan 
et al., 2007). Additional studies in vertebrates, as well as in the 
Drosophila model, are needed to provide further insight into the 
physiological role of Lipocalins, their regulation by stress signaling, as 
well as their interaction with Insulin signaling. Such insight promises 
to provide a deeper understanding of the coordination of metabolic 
adaptation in metazoans as well as of the etiology of diabetes and 
other metabolic diseases. 
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Materials and Methods 
 
Fly lines and handling 
 
Fly lines were as follows: OreR and Da-Gal4 from Bloomington stock 
center; hep1/FM6, gift from S. Noselli; ppl-Gal4, (Zinke, Kirchner et 
al. 1999), gift from Michael Pankratz; dot-Gal4, gift from W.X. Li; 
UAS-Hep, gift from M. Mlodzik; UAS-bskRNAi, from Vienna Drosophila 
RNAi Center (Transformant ID 34138). 
Generation of the NLaz deletion strain (NLazSceI) is described in 
(Rong, Titen et al. 2002). Isogenic knock-out and control lines were 
generated by outcrossing NLazSceI knock-out flies into a w1118-CS10 
wild type strain. Sister lines containing either the wild type allele of 
NLaz (line NLazCNW14) or the mutant allele (line NLazNW5) were 
selected by PCR and subsequent SceI restriction digest. The line 
w1118-CS10 is a 10 generations outcross of w
1118 into the CS 
background.  
P-element mediated transformation of w1118 mutant flies was used to 
generate pUASt-NLaz. The full-length NLaz cDNA was amplified 
using PCR (as annotated in flybase), and it was inserted into pUASt 
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via ligation into EcoRI and XbaI sites. Three different independent 
insertion lines of pUASt-NLaz were used in our experiments, 
producing identical results. Flies were fed a cornmeal and molasses 
based diet, and were reared at 25C. For each experiment, care was 
taken to ensure flies developed at an equal larval density. 
 
Starvation tolerance and nutrient measurement 
 
Starvation experiments were performed by placing flies in empty vials 
or vials with water-soaked filters, as indicated in figure legends. For 
glucose, trehalose, glycogen, and triglyceride measurements, cohorts 
of 10 male flies were weighed prior to homogenization in 100 μL 
homogenization buffer (0.01M KH2PO4, 1 mM EDTA, pH 7.4).  
Homogenates were spun for 2 min. at 3,000 rpm, and the 
supernatant was collected.  10μL of homogenate was used in each of 
the following assays: Glucose:  Homogenate was pipetted into 500 
μL glucose reagent (Glucose (HK) Assay Kit, Sigma).  Samples were 
incubated at room temperature for 15 min. and absorbance was 
measured at 340 nm versus deionized water.  Trehalose:  0.5 μL 
Trehalase from porcine kidney (Sigma) was added to homogenate.  
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After 1 hour incubation at 37C, glucose was measured as above, 
and the concentration of glucose prior to trehalase digestion was 
subtracted.  Glycogen:  10 μL of starch assay reagent (Starch assay 
kit, Sigma) was mixed with homogenate.  Sam ples were shaken at 
60C for 15 minutes.  10 μL of sample was used in glucose assay 
already described.  Absorbance of glucose prior to digestion with 
starch assay reagent was subtracted from final absorbance.   
 
Triglyceride assay 
 
Homogenate was added to 500 μL of activated triglyceride reagent 
(Liquicolor Triglycerides, Stanbio) and reaction was incubated at 
room temperature for 10 minutes.  The absorbance was measured at 
500 nm relative to activated triglyceride reagent.  All metabolic 
measurements were normalized to fly weight.   
 
Paraquat and hyperoxia treatments 
 
Flies were starved for 3-6 hours prior to re-feeding with 25 mM or 50 
mM paraquat (Methyl Viologen, Sigma) in 5% sucrose.  Paraquat 
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solution was administered on soaked filters.  Flies were kept in the 
dark once re-fed. 
For hyperoxia, 20–30 2-day old adult males, were maintained in vials 
containing standard food within a Plexiglas enclosure of 28 x 28 x 24 
inches at room temperature (22–24°C). Oxygen (100%) was passed 
through the box at a constant rate of 300 ml/min. Survival was 
assayed daily. 
 
Lifespan analysis 
 
Flies were collected within 24 hr of eclosion and were separated by 
sex at 2-3 days of age in groups of 20. They were raised at 25ºC 
under a 12hr:12hr light cycle and transferred to fresh food vials every 
2-3 days.  
To ensure identical genetic backgrounds, Da-Gal4 was out-crossed 
10 times to w1118. Similarly, UAS-NLaz4 and UAS-NLaz8 were 
generated and maintained in the w1118 background, minimizing effects 
of genetic background variations and hybrid vigor in the progeny of 
the crosses studied. Remaining effects of genetic background and 
hybrid vigor can be assessed in lifespan differences between the 
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progenies of the two control crosses (UAS-NLaz x w1118 and Da-
GAL4 x w1118). Any GAL4-dependent modification of lifespan 
observed in the test cross (Da-GAL4 x UAS-NLaz), is thus due to the 
over-expression of the transgene. 
 
Real Time PCR 
 
RNA was prepared from whole flies or larvae using Trizol reagent 
(Invitrogen) according to package instructions.  Subsequently, 
Superscript reverse transcriptase (Invitrogen) and oligodT were used 
to generate cDNA. cDNA, diluted 1:100, served as template for real 
time PCR using SYBR green based detection.  All reactions were 
performed in triplicate, and melting curves were examined to ensure 
single products. Primer pairs utilized were as follows: 
 
rp49: 5'-CGGCACTCGCACATCATT,  
5'-AGCTGTCGCACAAATGGC; 
 
actin5C: 5'-CTCGCCACTTGCGTTTACAGT,  
    5'-TCCATATCGTCCCAGTTGGTC; 
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puc: 5'-CGAGGATGGGTTTGATTACGA,  
        5'-TCAGTCCCTCGTCAAATTGCT; 
 
NLaz: 5'-GCCAGAAGTAGAACGGATACCA,  
5'-ACTGGTGCAGCTGTAGACGAC; 
 
pepck:  5'-CCAGGACAATTGCGGTCTGT,  
  5'-CTGCAGCATCCATGTCGCT; 
 
l(2)efl: 5'-AGGGACGATGTCACCGTCTCT,  
 5'-CGAAGCAGACGCGTTTATCC; 
 
Quantification of tGPH membrane intensity 
 
Nuclear fluorescence was used to normalize membrane 
fluorescence. Fat bodies of 5 individual wandering third instar larvae 
were imaged using confocal microscopy and average fluorescence of 
membrane and nuclei was measured using the histogram function of 
NIH ImageJ. Intensity ratios were calculated for n=6-10 individual 
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cells from different fatbodies, and overall averages and standard 
deviations were calculated. 
 
Weight and wing measurements 
 
Sibling flies were used for comparisons.  Flies were weighed as 
cohorts of 10 flies in pre-weighed eppendorf tubes.  Wings were 
photographed, and size was determined by quantifying the number of 
pixels within each wing with adobe Photoshop. 
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Figures and Legends 
 
 
Figure 1: JNK is required for maintenance of metabolic 
homeostasis. 
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(A-E) Comparison of hemizygous hep1 males (hep1/y) to wild type 
OreR males.   
(A-C)  Carbohydrate and lipid content in homogenates prepared from 
populations of 10 flies prior to and after 6, 24, and 30 hours of wet 
starvation.  All measurements were normalized to the average weight 
of a single fly in its population. (A) Glucose. (B) Glycogen. (C) 
Triglycerides. 
(D) Real time PCR results from cDNA prepared from starved adult 
males collected 6, 24, and 30 hours after wet starvation. Levels of 
PEPCK are compared in starved conditions to fed controls (0 hours).  
All transcripts are normalized to actin5C. 
(E,F) Percent of male flies surviving after prolonged dry starvation. 
Population sizes were  (E) OreR: n=151; hep1: n=103. (F) DaG4/+: 
n=179; BskRNAi/+;DaG4/+: n= 138.  
(F, inset) Real time PCR on cDNA prepared from BskRNAi/+;DaG4/+ 
larvae. Levels of Bsk are compared to DAG4/+ controls. All 
transcripts are normalized to rp49. 
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Figure 2: JNK regulates transcription of NLaz. 
 
(A, B) Real time PCR measuring transcript levels of puc and NLaz in 
whole larvae (A) and dissected fatbody (B).  Larvae express Hepact 
under the control of the ubiquitous T80-Gal4 driver (A) or the fatbody 
pplG4 driver (B) combined with tubGal80ts. Genotypes: (A) w1118; 
T80Gal4, tubGal80ts/UAS-Hepact; control genotype: w1118; T80Gal4, 
tubGal80ts/+; (B) w1118; pplGal4, tubGal80ts/UAS-Hepact; control 
genotype: w1118; pplGal4, tubGal80ts/+. Larvae were reared at 18ºC 
until 96 hours after egg laying, heat shocked for 1.5 hours at 37ºC 
and left at 29ºC for 6 hours (A) or 3 hours (B) to activate the driver. 
Transcript levels are normalized to rp49. Averages and Standard 
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Deviations of three independent experiments are shown. p values 
were calculated using Student’s T test. 
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Figure 3: NLaz is required for maintenance of metabolic 
homeostasis. 
 
(A-E) Comparison of homozygous NLaz loss of function mutants 
(NLazNW5/NW5) to wild type isogenic controls (NLazC-NW-14/C-NW-14).   
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(A-C) Carbohydrate and lipid content in homogenates prepared from 
populations of 10 male flies prior to and after 6, 24, and 30 hours of 
wet starvation.  All measurements were normalized to the average 
weight of a single fly in its population.  (A)  Glucose. (B) Glycogen (C) 
Triglycerides. 
(D). Real time RT-PCR results from cDNA prepared from starved 
adult males collected 6, 24, and 30 hours after wet starvation.  Levels 
of PEPCK are compared in starved conditions to fed controls (0 
hours).  All transcripts are normalized to actin5C. 
 (E,F) Percent of male flies surviving after being exposed to 
prolonged dry starvation.  Genotypes: (E) +/+: n=227; NLazNW5/NW5: 
n=254. (F)  pplG4/+;+/+: n=102; pplG4/+;UASNLaz/+: n=115. To 
equalize culture conditions and genetic backgrounds, sibling F1 
progeny derived from out-crossed w1118; pplGal4/pplGal4 with out-
crossed w1118; UAS-NLaz/+ are compared.  
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Figure 4: Nlaz acts downstream of JNK to maintain metabolic 
homeostasis. 
 
(A) Percent of male flies surviving after being exposed to prolonged 
dry starvation.   
(B) Glucose and lipid content in homogenates prepared from 
populations of 10 male flies after 24 hours of wet starvation. 
(A, B) Genotypes: hep1/y: n=105; hep1/y;pplG4/+;UASNLaz/+: n=74; 
OreR: n=114. 
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Figure 5: NLaz acts downstream of JNK to promote oxidative 
stress tolerance. 
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(A) NLaz is induced in flies exposed to oxidative stress. Levels of 
NLaz are compared using cDNA prepared from wild type OreR flies 
fed 50 mM paraquat in 5% sucrose to those fed 5% sucrose alone for 
24 hours. Levels of puc are shown for comparison. All transcript 
levels are normalized to actin5C. p values are calculated using 
Student’s T test. 
(B) Oxidative stress sensitivity in NLaz mutants. Survival after 
exposure to paraquat.  NLazCNW14 N=70, NLazNW5 N=117.  Log rank 
test, p<0.001. 
(C) Over-expressing UAS-NLaz using the ppl-Gal4 driver promotes 
tolerance to paraquat.  Comparison of siblings of the following 
genotypes:  pplG4/+, n=103; pplG4/+;UASNLaz/+, n=134.   
(D) Stress sensitivity of NLaz mutants cannot be improved by JNK 
activation. Survival after exposure to paraquat.  Populations of the 
following genotypes and numbers of individuals were used: pplG4/+ 
n= 61; pplG4/UASHep n=97; pplG4,NW5/NW5 n=135; 
pplG4,NW5/UASHep,NW5 n=59. Log rank test for pplG4/UASHep: 
p<0.001. 
(E and F) NLaz gene dose influences lifespan. (E) Male longevity at 
25ºC. Groups of 20 flies per vial. NLazCNW14/CNW14 N=193, NLazNW5/NW5 
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N=457. Log-rank test, p < 0.001. (F) Overexpression of NLaz 
increases normal survival of males at 25ºC. Overexpressing UAS-
NLaz4 using DaG4 as a ubiquitous driver increases mean and 
maximum life spans in normal conditions. DaG4/+, n=112; UAS-
NLaz4/+, n=78; DaG4/UAS-NLaz4, n=104; Log-rank test: p<0.001 
(comparing UAS-NLaz and DaG4/UAS-NLaz). 
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Figure 6: NLaz antagonizes IIS. 
 
(A-C) tGPH fluorescence (Britton, Lockwood et al. 2002) in larval 
fatbodies.  (A) +/+. (B) NLazNW5/NW5. Membrane localization of tGPH 
is increased in NLaz mutants compared to isogenic wild-type 
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controls, indicating elevated PI3K activity. (C) Ratios of average 
membrane vs. nuclear fluorescence as determined using NIH ImageJ 
on images of fatbody cells of independent individuals. n=6 for +/+, 
n=10 for NLazNW5. P value from Student’s T test. 
(D) Over-expression of NLaz in the fatbody results in elevated 
hemolymph glucose levels. Experiments were performed in larvae of 
the following genotypes: pplG4/+;+/+; pplG4/+; UASNlaz/+.   
(E) NLaz cannot promote further starvation tolerance of chico1 
mutant flies.  Percent survival of males of the following genotyps in 
response to prolonged dry starvation:     +/+, n=112; chico/+, n=124, 
chico/pplG4, n=122; chico/pplG4;UASNLaz/+, n=124; 
chico/+;UASNLaz/+, n=78. 
(F-H) Comparison of adult sibling males of the following genotypes:  
ppl,NW5/+;+/+; ppl,NW5/+;UASNlaz/+. 
(F) Overall weight is decreased in NLaz over-expressing animals. 
Fresh weight of males of the indicated genotypes. 
(G and H) NLaz levels affect wingsize. Comparison of wing sizes of 
sibling NLaz mutant flies with or without over-expression of NLaz in 
the fatbody. (A) Wing sizes were measured using Adobe Photoshop. 
(B) Overlay to visualize wing size differences. 
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Figure 7: Proposed role of NLaz in promoting stress tolerance 
and metabolic homeostasis in the fly.   
 
JNK-mediated induction of NLaz in the fatbody is required for 
regulation of metabolic homeostasis and stress tolerance. 
Accordingly, NLaz over-expression promotes stress tolerance and 
extends lifespan. As suggested by our data and reported for related 
168 
 
vertebrate Lipocalins, NLaz might interfere with Insulin signaling 
activity, thus coordinating metabolic changes throughout the 
organism. At the same time, JNK represses transcription of dilp2 in 
IPCs. Together, these two mechanisms antagonize IIS in the 
periphery, thereby promoting stress tolerance systemically.  
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Supplemental Figures and Legends 
 
Figure S1.  
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(A) Trehalose content in homogenates prepared from populations of 
10 flies prior to and after 6, 24, and 30 hours of wet starvation.  (A) 
hep1 and +/+. All measurements were normalized to the average 
weight of a single fly in its population. 
(B) dilp2, dilp3 and dilp5 transcript levels in hep1 mutants relative to 
+/+ controls determined by real time RT-PCR.  All transcript levels 
were normalized to actin5C. No significant differences are observed 
in transcript levels of ILPs between hep1 and wild-type in ad libitum 
conditions (left panel). No differences are observed in dilp2 transcript 
levels in starved flies (right panel).   
(C) Real time RT-PCR to measure changes in transcription of 
selected potential secreted metabolic regulators in response to JNK 
activation. The heat shock-inducible TARGET system was utilized. 
Average fold induction (between Hepact expressing and wild-type 
controls) of non-heat shocked (reared at 18 degrees) and heat 
shocked samples are shown. Actin5C expression was used for 
normalization.  
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(D) Trehalose content of NLazNW5/NW5 compared to isogenic wild-type 
controls. 
 
Figure S2. 
(A, B) Percent survival in response to prolonged dry starvation.  
Genotypes: (A) pplG4/+, n= 181, pplG4/+;UASKarl/+, n= 181. (B) 
hep1/y, n=134, +/+, n=130, hep1/y;DorothyG4/+;UASNLaz/+, n=46.  
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Figure S3. 
(A) Over-expression of NLaz enhances resistance to hyperoxia. 
Overexpressing UAS-NLaz4 and UAS-NLaz8, using DaG4 as a 
ubiquitous driver protects from 100% oxygen-induced mortality. 
DaG4/+, n=157; UAS-NLaz4/+, n=106; DaG4/UAS-NLaz4, n=84; 
UAS-NLaz8/+, n=104; DaG4/UAS-NLaz8, n=107. Log rank test for 
UAS-NLaz4: p<0.001. Log rank test for UAS-NLaz8: p<0.001. 
(B) Overexpressing UAS-NLaz using DaG4 protects from paraquat-
induced mortality. UAS-NLaz4 and UAS-NLaz8 are independent 
insertion lines of the same construct. DaG4/+, n=118; UAS-NLaz4/+, 
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n=102; DaG4/UAS-NLaz4, n=132; UAS-NLaz8/+, n=94; DaG4/UAS-
NLaz8, n=116. Log rank test comparing UAS-NLaz4 and DaG4/UAS-
NLaz4: p<0.001. Log rank test for UAS-NLaz8: p<0.001  
(C, D) Percent surival in response to infection with E. faecalis.  
Genotypes: (C).  DorothyG4/+ mock, n=21, DorothyG4/+, n=111; 
DorothyG4/+;UASNLaz/+, n=108. (D) DorothyG4/+, mock, n= 31; 
DorothyG4/+, n=84; DorothyG4/+; UASKarl/+, n=60, 
DorothyG4/+;pWizKarl/+, n=56.  
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Figure S4. 
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(A) Over-expression of NLaz induces expression of the FoxO target 
gene l(2)efl.  Real time RT-PCR in whole larvae of the following 
genotypes:  pplG4/+;UASNLaz/+; pplG4/+.  
(B) Real time RT-PCR demonstrates that NLaz transcript levels are 
unchanged in chico1 heterozygous mutants. 
(C) Real time RT-PCR measuring levels of dilp2, dilp3, and dilp5 in 
cDNA prepared from dissected larval brains. Larval genotypes were 
as follows: +/+; NLazNW5/NW ; pplG4/+; pplG4/+;UASNLaz/+; 
pplG4/UASHep .  Transcript levels were normalized to Actin5C. 
(D) Real time RT-PCR measuring levels of dilp2, dilp3, and dilp5 in 
adult heads from flies of the following genotypes:  +/+, NLazNW5/NW5 
pplG4/+, pplG4/+;UASNLaz/+, pplG4/UASHep.  All transcript levels 
are normalized to Actin5C. 
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Figure S5. NLaz over-expression from an alternative transgenic 
line promotes longevity. 
Overexpressing UAS-NLaz8, using DaG4 as a ubiquitous driver, 
increases mean and maximum lifespans in normal conditions. 
UAS-NLaz8/+, n=108; DaG4/UAS-NLaz8, n=92. Log-rank test: 
p<0.001. 
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Figure S6. NLaz is secreted 
 
HA-tagged NLaz (lanes 1 and 2) can be detected in the medium of 
S2 cells after 6 hrs of conditioning. Cell pellet (P) and supernatant (S) 
are shown. Related lipocalins are also secreted: human ApoD (lanes 
3 and 4) and Drosophila GLaz (lanes 5 and 6).  
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Supplemental Material and Methods 
 
Transfection of S2 cells and detection of secreted proteins 
 
S2 cells were maintained as adherent cultures at room temperature in 
Schneider’s medium supplemented with 10% FBS. Cells were 
transfected with the pAHW plasmid (Murphy Laboratory), into which 
the Lipocalin cDNA had been subcloned using gateway 
recombination, fusing the protein with a C-terminal 3xHA tag. 
Regulation of trafficking of the fusion protein by the N-terminal signal 
sequence was thus maintained. Transfection was performed with the 
Fugene HD (Roche) reagent in a 9:2 ratio per the manufacturer’s 
instructions.  
S2 cells were transfected with this construct and allowed to express 
the protein for 48 hours. The transfection medium was removed, and 
new medium was conditioned for 6 hours. Cells were separated from 
the conditioned medium by centrifugation (10’, 5000rpm), and lysed 
in standard lysis buffer with protease inhibitors. An aliquot of the cell 
lysate and one from the conditioned medium were assayed for 
protein concentration (BCA assay, Pierce), and each adjusted to 
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1ug/uL. 100uL of these protein samples were mixed with SDS sample 
buffer, and denatured by heating to 95°C for 5 minutes. 10 ug of total 
protein from each sample were run on a denaturing SDS-page gel 
(Nupage, Invitrogen), and transferred to PVDF membrane following 
standard protocols. The membrane was then probed for HA reactivity 
using an HRP-conjugated anti-HA antibody (Roche), and detected 
using ECL West Dura substrate (Pierce). 
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